Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3017315	u-amyl	U/l (u/l)	2099	2628	0.04%
3017315	u-amyl	— (—)	179	192	100.00%	Distribution not available
3017315	u-amyl	U/L (u/l)	115	124	0.00%
3017315	u-amyl	U/l_______ (u/l)	9	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Acute pancreatitis

335

316

10.95

309.49

1.7

1.1

971.69

198.97

u/l

4.66

289

297

Acute pancreatitis (for exclusion)

335

371

9.32

275.41

1.7

1.2

971.69

225.44

u/l

4.35

289

344

Abdominal and pelvic pain

733

694

5.35

272.21

1.3

1.1

342.33

375.93

u/l

0.17

671

652

Disorders of gallbladder, biliary tract and pancreas

860

1293

4.18

269.14

1.4

1.1

473.81

207.83

u/l

4.68

776

1231

Symptoms and signs involving the digestive system and abdomen

682

694

4.96

235.36

1.3

1.1

342.26

375.93

u/l

0.17

621

652

Chronic pancreatitis

202

187

11.17

189.20

1.9

1.1

518.26

210.54

u/l

1.87

174

178

Any gastric operation

453

476

4.80

151.71

1.3

1.1

294.03

219.44

u/l

1.29

416

450

GASTRO-related operations

453

476

4.80

151.71

1.3

1.1

294.03

219.44

u/l

1.29

416

450

Cholelithiasis, broad definition with cholecystitis

592

1198

3.31

138.59

1.3

1.1

243.29

205.09

u/l

0.84

544

1138

Cholelithiasis

564

1186

3.27

130.47

1.3

1.1

241.22

204.46

u/l

0.77

517

1126

Other diseases of intestines

669

1265

2.96

123.65

1.4

1.2

299.51

364.37

u/l

0.52

626

1175

Diseases of oesophagus, stomach and duodenum

695

1492

2.77

116.19

1.4

1.2

267.19

328.68

u/l

0.86

638

1406

Low back pain

519

1122

3.14

112.59

1.4

1.2

224.69

394.24

u/l

2.70

493

1045

Substance abuse, excluding more controls

402

1005

3.37

103.75

1.4

1.2

293.49

353.10

u/l

0.53

371

936

Pain (limb, back, neck, head abdominally)

365

456

4.03

100.72

1.3

1.1

350.24

341.83

u/l

0.04

339

420

418

1183

3.18

100.15

1.4

1.2

421.97

317.34

u/l

0.81

379

1107

Alcohol use disorder, Swedish definition

403

1139

3.24

100.11

1.4

1.2

460.86

316.95

u/l

1.14

365

1065

432

1220

3.10

98.71

1.4

1.2

450.59

308.42

u/l

1.24

392

1143

Diverticular disease of intestine

458

920

3.12

95.79

1.3

1.2

304.44

396.42

u/l

0.53

428

851

Lower back pain or/and sciatica

671

1671

2.51

94.62

1.4

1.2

237.78

345.83

u/l

1.98

639

1547

Cholecystectomy

486

1470

2.83

93.73

1.4

1.2

324.12

309.22

u/l

0.10

446

1374

Nausea and vomiting

172

300

5.64

90.42

1.4

1.1

305.65

257.81

u/l

0.27

159

272

Tramadol

490

1024

2.89

89.48

1.4

1.2

291.82

379.01

u/l

0.75

457

950

Sciatica+with lumbago

348

940

3.30

88.58

1.3

1.2

226.96

419.15

u/l

2.29

333

871

Gastrointestinal diseases

285

325

4.42

87.58

1.3

1.1

337.00

211.59

u/l

1.76

263

308

Substance abuse

402

1265

2.97

86.88

1.4

1.2

293.49

347.46

u/l

0.55

371

1181

Other functional intestinal disorders

312

821

3.48

86.77

1.5

1.2

203.71

371.51

u/l

2.65

285

758

Pain in throat and chest

509

1087

2.79

86.60

1.4

1.2

235.26

371.37

u/l

2.18

470

1019

Hernia of abdominal wall, postoperative

133

192

6.96

86.51

1.6

1.1

263.96

214.86

u/l

0.66

125

180

Other diseases of pancreas

107

122

9.01

86.12

1.5

1.1

765.19

201.30

u/l

1.79

115

Dorsalgia

571

1143

2.66

86.09

1.4

1.2

259.67

391.34

u/l

1.69

541

1065

Headache

423

1121

2.93

85.21

1.4

1.2

259.77

367.82

u/l

1.20

397

1049

Mental and behavioural disorders due to psychoactive substance use

408

1293

2.91

84.60

1.4

1.2

289.86

350.35

u/l

0.66

376

1207

Irritable bowel syndrome

212

485

4.42

84.46

1.5

1.1

229.53

325.44

u/l

1.35

199

443

Pain in joint

284

441

3.98

83.95

1.4

1.1

248.47

347.92

u/l

0.64

264

406

Oxycodone

279

659

3.65

81.93

1.5

1.2

219.58

407.32

u/l

1.79

269

610

General symptoms and signs

601

1190

2.54

81.60

1.4

1.2

293.05

362.43

u/l

0.69

558

1113

Abnormalities of breathing

505

1100

2.64

76.96

1.3

1.2

293.57

372.28

u/l

0.50

465

1031

Other dorsopathies, not elsewhere classified

557

1145

2.54

76.38

1.3

1.2

251.76

391.12

u/l

1.90

516

1066

Mental and behavioural disorders due to alcohol

337

1124

2.88

69.14

1.5

1.2

319.69

359.45

u/l

0.31

308

1047

Other soft tissue disorders, not elsewhere classified

524

1235

2.42

67.39

1.3

1.2

284.79

300.77

u/l

0.11

484

1157

Parasetamol

361

615

2.98

65.60

1.3

1.2

409.24

355.12

u/l

0.23

336

567

Functional dyspepsia

200

530

3.81

65.43

1.4

1.2

202.60

287.40

u/l

1.59

185

493

Mental and behavioural disorders due to alcohol, excluding acute intoxication

303

1032

2.93

65.04

1.5

1.2

324.70

370.58

u/l

0.34

277

961

Pain, not elsewhere classified

202

544

3.75

64.54

1.5

1.2

194.26

411.23

u/l

1.86

190

498

Other intervertebral disc disorders

448

1058

2.54

64.16

1.3

1.2

276.20

402.80

u/l

1.27

414

986

Alcohol use disorder, ICD-based

284

954

3.00

63.67

1.5

1.2

336.95

372.69

u/l

0.23

259

885

Gastro-oesophageal reflux disease

401

1338

2.54

63.10

1.2

286.46

333.35

u/l

0.25

364

1257

Codeine

486

1089

2.42

61.54

1.4

1.1

283.48

368.13

u/l

0.79

455

1011

Fever of other and unknown origin

326

1023

2.78

61.43

1.3

1.2

275.86

348.07

u/l

0.60

313

953

Spondylopathies

418

972

2.55

60.62

1.4

1.2

197.46

416.68

u/l

3.69

393

903

Pain in limb

452

1219

2.37

57.09

1.2

247.68

295.71

u/l

0.41

414

1142

Other headache syndromes

273

950

2.88

57.05

1.4

1.2

235.48

322.70

u/l

0.95

253

881

Pain in thoracic spine

121

243

5.04

56.69

1.3

1.2

171.93

417.18

u/l

1.89

115

226

Alcohol dependence

200

585

3.46

56.55

1.6

1.2

313.16

467.08

u/l

0.95

179

540

Dorsopathies

516

1148

2.28

56.53

1.3

1.2

261.72

390.55

u/l

1.63

478

1068

Other diseases of biliary tract

120

7.04

54.63

1.4

1.2

244.97

189.54

u/l

0.27

114

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

177

485

3.63

53.99

1.4

1.2

283.89

323.00

u/l

0.21

166

448

Dysphagia

131

294

4.49

53.61

1.3

1.1

187.87

391.69

u/l

1.09

120

270

Constipation

502

1566

2.18

53.41

1.3

1.2

280.49

325.29

u/l

0.27

458

1466

Opioids

485

1105

2.27

53.00

1.4

1.1

276.18

371.32

u/l

0.98

456

1026

Dyspnoea

501

1680

2.16

52.91

1.3

1.2

197.52

350.40

u/l

4.30

464

1569

Mood disorders, excluding more controls

483

1288

2.21

51.35

1.3

1.2

276.89

352.80

u/l

0.80

443

1200

Concussion

280

794

2.75

50.53

1.3

1.2

307.99

329.42

u/l

0.12

264

750

Lumbar disc prolapse

339

1007

2.50

50.39

1.3

1.2

277.47

413.11

u/l

1.26

315

936

Infections, IBD-co-morbidities

104

125

5.90

50.28

1.2

1.1

180.73

288.75

u/l

1.69

118

Anxiety disorders, excluding more controls

432

1217

2.28

50.24

1.3

1.2

256.02

356.13

u/l

1.16

398

1132

Alcohol abuse, main dg, excluding more controls

122

274

4.51

50.01

1.6

1.2

260.05

412.05

u/l

0.99

110

255

Cervicobrachial syndrome

147

381

3.89

49.75

1.5

1.2

206.11

496.62

u/l

2.09

141

352

Symptoms and signs involving the circulatory and respiratory systems

485

1101

2.22

49.47

1.3

1.2

266.78

372.14

u/l

1.33

442

1032

Codeine or tramadol medication

586

1572

2.03

49.29

1.4

1.2

289.20

332.60

u/l

0.44

549

1467

Shoulder lesions

408

1057

2.32

48.82

1.3

1.2

288.95

300.29

u/l

0.08

385

986

Anaemias

134

188

4.60

48.20

1.7

1.1

242.26

387.77

u/l

0.50

119

179

Any mental disorder

540

1302

2.08

47.50

1.4

1.2

273.54

350.20

u/l

0.86

496

1214

Paralytic ileus and intestinal obstruction

159

450

3.56

47.26

1.6

1.2

282.75

454.72

u/l

1.01

150

409

Intracranial trauma

305

802

2.58

47.06

1.3

1.2

308.29

328.33

u/l

0.12

288

758

Spondylosis

290

883

2.58

46.43

1.3

1.2

187.15

424.54

u/l

3.71

271

822

Substance use, excluding alcohol

148

407

3.68

46.07

1.5

1.2

205.74

399.26

u/l

2.06

139

376

Benzodiazepine use

530

1794

2.00

45.18

1.4

1.2

249.00

334.45

u/l

1.31

494

1676

Other antidepressants

519

1289

2.06

44.72

1.3

1.2

290.17

353.63

u/l

0.64

475

1207

Asthma, excluding more controls

374

818

2.36

44.22

1.4

1.2

238.08

395.04

u/l

1.74

353

763

Diarrhoea and gastroenteritis of presumed infectious origin

389

1603

2.18

43.83

1.3

1.2

243.65

328.86

u/l

1.29

356

1495

Intestinal infectious diseases

496

1848

2.00

43.31

1.3

1.2

252.09

333.52

u/l

1.30

458

1729

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

523

1702

1.98

42.68

1.3

1.2

246.02

339.01

u/l

1.58

479

1595

Intestinal infectious diseases, including avohilmo, including avohilmo

578

1680

1.92

42.05

1.3

1.2

233.96

340.39

u/l

2.06

533

1574

Diseases of the digestive system

275

1118

2.46

41.91

1.4

1.2

274.49

341.90

u/l

0.59

254

1034

Malaise and fatigue

271

848

2.53

41.79

1.2

192.61

351.35

u/l

2.08

251

781

Asthma (mode)

383

892

2.26

41.78

1.3

1.2

237.45

377.25

u/l

1.64

363

833

Asthma

385

881

2.26

41.70

1.4

1.2

238.24

379.63

u/l

1.64

363

822

Asthma (only as main-diagnosis), excluding more controls

345

818

2.34

41.18

1.4

1.2

215.95

395.04

u/l

2.18

329

763

Psychiatric diseases

461

1112

2.08

40.64

1.3

1.2

306.86

365.30

u/l

0.46

420

1038

Oral corticosteroids

539

1638

1.94

40.56

1.4

1.2

300.61

326.27

u/l

0.15

509

1528

Asthma (only as main-diagnosis)

356

881

2.27

39.73

1.4

1.2

215.89

379.63

u/l

2.11

340

822

Mood [affective] disorders

522

1744

1.92

39.41

1.3

1.2

271.58

332.43

u/l

0.77

482

1632

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

125

342

3.70

39.30

1.4

1.3

248.56

312.58

u/l

0.46

116

316

Mood disorders

522

1744

1.92

39.20

1.3

1.2

271.58

332.43

u/l

0.77

482

1632

Depression or dysthymia

328

768

2.34

39.08

1.4

1.2

285.25

394.82

u/l

0.81

303

715

Depression

491

1689

1.95

38.97

1.3

1.2

260.63

335.78

u/l

1.06

452

1580

Other/unspecified dorsalgia

196

701

2.78

38.38

1.3

1.2

254.31

415.87

u/l

1.22

191

641

Inflammatory bowel disease treatment related agents

563

1667

1.88

38.34

1.4

1.2

286.30

323.51

u/l

0.25

529

1554

Rotator cuff syndrome

327

1000

2.26

38.33

1.3

1.2

282.41

304.71

u/l

0.17

307

935

Symptoms and signs involving cognition, perception, emotional state and behaviour

493

1709

1.93

38.20

1.3

1.2

247.53

335.08

u/l

1.34

454

1607

Myalgia

146

452

3.26

37.86

1.3

1.2

223.67

312.51

u/l

1.09

136

417

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

133

164

4.08

37.74

1.3

1.1

362.27

394.32

u/l

0.08

122

152

Alcohol abuse, main dg

122

339

3.64

37.52

1.6

1.2

260.05

439.39

u/l

1.42

110

313

Other bacterial diseases, including avohilmo

506

1659

1.91

37.24

1.3

1.2

232.64

342.45

u/l

2.03

464

1556

Dizziness and giddiness

393

1495

2.05

37.16

1.3

1.2

257.75

336.90

u/l

0.91

360

1401

Suicide or other Intentional self-harm

163

545

3.02

37.14

1.4

1.3

288.43

348.04

u/l

0.33

153

496

Acute alcohol intoxication, ICD10

144

449

3.24

36.97

1.5

1.2

280.76

467.03

u/l

1.21

130

413

Poisoning by medicine

149

478

3.15

36.47

1.4

1.3

303.87

354.71

u/l

0.25

139

440

Injuries to the head

552

1785

1.84

35.88

1.3

1.2

272.37

328.36

u/l

0.71

524

1659

429

1253

2.01

35.85

1.3

263.73

351.98

u/l

0.93

397

1178

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

429

1253

2.01

35.85

1.3

263.73

351.98

u/l

0.93

397

1178

Poisoning by drugs, medicaments and biological substances

157

529

2.99

35.31

1.4

1.3

316.48

348.08

u/l

0.15

146

487

ILD medications: prednisolone, methylprednisolone, prednisone

527

1582

1.86

34.73

1.4

1.2

306.15

324.76

u/l

0.10

494

1475

Migraine

266

889

2.34

34.73

1.4

1.2

265.53

300.06

u/l

0.29

253

828

540

1482

1.85

34.50

1.3

1.2

257.49

352.88

u/l

1.24

504

1384

Anxiety (asthma-related co-morbidities)

305

1056

2.20

34.50

1.4

1.2

267.66

325.65

u/l

0.53

277

992

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

177

645

2.76

34.46

1.4

1.3

283.89

326.17

u/l

0.24

166

591

Anxiety disorders

454

1632

1.91

34.44

1.3

1.2

256.30

337.87

u/l

1.15

420

1530

Other or unspecified ileus, impaction or obstruction

110

302

3.67

34.40

1.7

1.2

225.39

460.85

u/l

1.57

102

275

Neurotic, stress-related and somatoform disorders

450

1625

1.91

34.14

1.3

1.2

257.38

337.14

u/l

1.10

416

1523

Acute alcohol intoxication

161

561

2.89

34.10

1.5

1.2

273.57

472.08

u/l

1.50

147

519

ILD medications

543

1602

1.83

34.06

1.4

1.2

299.86

322.74

u/l

0.13

508

1494

Soft tissue disorders

466

1239

1.93

33.85

1.3

1.2

286.06

300.20

u/l

0.09

427

1160

Acute upper respiratory infections

505

1637

1.85

33.75

1.2

267.12

339.16

u/l

0.84

472

1526

First line medication for Crohn's disease

527

1544

1.84

33.59

1.3

1.2

312.66

316.66

u/l

0.02

491

1441

Other disorders of fluid, electrolyte and acid-base balance

195

710

2.60

33.36

1.5

1.2

279.11

366.70

u/l

0.51

177

665

Complications of surgical and medical care, not elsewhere classified

493

1791

1.84

33.07

1.3

1.2

307.05

316.01

u/l

0.06

458

1673

All kidney diseases

482

1751

1.85

32.79

1.3

1.2

203.25

344.99

u/l

4.07

452

1630

Cervical disc disorders

182

697

2.63

32.16

1.3

1.2

189.24

467.88

u/l

3.24

172

643

Examination and observation for other reasons

326

864

2.14

31.84

1.3

1.2

225.86

368.97

u/l

2.00

301

814

Asthma-related infections

311

1474

2.07

31.35

1.3

1.2

206.94

335.45

u/l

2.77

291

1360

Asthma, hospital admission 2, infections

311

1474

2.07

31.35

1.3

1.2

206.94

335.45

u/l

2.77

291

1360

Other gastritis (incl. Duodenitis)

130

422

3.11

31.25

1.5

1.2

353.12

442.76

u/l

0.32

121

393

Influenza and pneumonia

507

1741

1.80

31.20

1.3

1.2

267.53

329.49

u/l

0.77

467

1631

Hernia

455

1636

1.85

31.16

1.4

1.2

396.02

305.85

u/l

0.43

415

1529

COPD/asthma related infections

467

1253

1.87

30.82

1.2

1.3

279.83

351.98

u/l

0.68

426

1178

COPD/asthma/ILD related infections

467

1253

1.87

30.82

1.2

1.3

279.83

351.98

u/l

0.68

426

1178

Cough

204

781

2.45

30.76

1.2

219.56

399.79

u/l

1.87

186

728

Implicit Sepsis

382

1455

1.94

30.70

1.2

1.3

274.77

347.50

u/l

0.76

349

1356

Other bacterial diseases

462

1673

1.83

30.60

1.3

243.19

340.02

u/l

1.51

422

1566

Complications of procedures, not elsewhere classified

407

1751

1.88

30.21

1.3

1.2

307.69

318.03

u/l

0.06

379

1634

Personality disorders, excluding more controls

132

442

3.00

29.92

1.4

1.2

260.31

342.12

u/l

0.46

121

406

Other specific joint derangements/joint disorders

357

1120

1.99

29.83

1.4

1.2

233.20

376.08

u/l

2.10

329

1047

Symptoms and signs concerning food and fluid intake

162

4.48

29.50

1.3

1.1

237.67

315.73

u/l

0.51

151

Spinal stenosis

235

755

2.30

29.40

1.4

1.2

175.60

440.67

u/l

3.43

219

701

Nerve, nerve root and plexus disorders

509

1736

1.77

29.17

1.3

1.2

271.97

320.25

u/l

0.59

467

1630

Excessive earwax

329

1513

1.98

29.10

1.3

308.31

319.61

u/l

0.07

310

1396

243

1101

2.20

28.97

1.3

1.2

212.97

371.37

u/l

2.54

228

1010

Neurological diseases

373

956

1.96

28.40

1.2

304.56

332.12

u/l

0.19

337

904

Emergency coronary revascularization (for ACS)

403

1299

1.88

28.23

1.3

1.2

233.71

376.62

u/l

2.34

368

1206

Cystitis

395

1245

1.89

28.19

1.5

1.2

202.93

349.46

u/l

2.89

373

1164

Cervicalgia

111

350

3.19

28.07

1.4

1.2

257.43

404.35

u/l

1.11

104

320

Gastroduodenal ulcer

139

498

2.80

27.86

1.4

1.2

293.20

383.98

u/l

0.41

124

464

Episodal and paroxysmal disorders

487

1388

1.78

27.80

1.3

1.2

329.46

324.75

u/l

0.02

450

1301

Asthma, including avohilmo

549

1771

1.71

27.71

1.3

1.2

224.96

347.80

u/l

2.96

518

1646

Haemorrhoids and perianal venous thrombosis

164

638

2.57

27.68

1.2

188.88

387.91

u/l

2.89

155

585

All anxiety disorders

311

1210

2.00

27.66

1.4

1.2

264.70

329.83

u/l

0.69

283

1132

Intestinal stricture

177

725

2.46

27.29

1.5

1.2

281.94

419.02

u/l

0.93

168

668

Non-selective monoamine reuptake inhibitors

196

806

2.35

27.07

1.4

1.2

212.65

387.29

u/l

1.94

175

750

Chronic lower respiratory diseases

555

1726

1.70

26.95

1.3

1.2

243.19

347.62

u/l

2.16

522

1605

Acute gastritis

104

5.26

26.72

1.4

1.2

336.31

259.52

u/l

0.16

Coronary revascularization (ANGIO or CABG)

373

1202

1.89

26.72

1.3

1.2

233.85

378.90

u/l

2.15

344

1116

Percutaneous Coronary Intervention

372

1201

1.89

26.61

1.3

1.2

234.19

379.15

u/l

2.14

343

1115

Cardiac arrhythmias

273

836

2.10

26.50

1.2

280.35

403.64

u/l

1.03

250

792

Neurological diseases, wide definition

124

193

3.24

26.02

1.3

1.1

398.50

274.23

u/l

0.61

113

182

Implicit Sepsis, including avohilmo

393

1548

1.82

25.86

1.2

1.3

274.41

340.11

u/l

0.71

360

1449

Candidiasis, including avohilmo

170

701

2.44

25.86

1.4

1.2

213.44

294.32

u/l

1.50

159

647

Acute upper respiratory infections of multiple and unspecified sites

362

1421

1.86

25.85

1.3

1.2

271.24

334.51

u/l

0.56

335

1324

Type 2 diabetes

459

1515

1.76

25.83

1.3

1.2

202.31

349.52

u/l

3.97

418

1420

Other symptoms and signs involving the digestive system and abdomen

172

4.09

25.69

1.3

1.1

241.20

228.17

u/l

0.13

159

Cervicocranial syndrome

168

4.15

25.67

1.2

204.98

334.82

u/l

1.15

153

Implicit bacterial Sepsis, including avohilmo

238

931

2.14

25.55

1.2

267.01

366.80

u/l

0.76

215

862

Certain infectious and parasitic diseases

427

1186

1.81

25.44

1.3

1.2

304.22

312.12

u/l

0.04

386

1111

Bronchitis

503

1779

1.70

25.35

1.2

246.98

336.73

u/l

1.33

463

1668

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

423

1615

1.77

25.29

1.2

1.3

259.01

335.30

u/l

1.01

390

1513

Renal tubulo-interstitial diseases

413

1709

1.78

25.24

1.2

212.74

333.42

u/l

2.59

385

1590

Hypo-osmolality and hyponatraemia

113

381

2.97

25.15

1.4

1.2

197.38

311.67

u/l

1.44

101

355

Noninfective enteritis and colitis

242

1168

2.08

25.07

1.3

275.98

353.75

u/l

0.63

224

1076

Major coronary heart disease event

388

1273

1.83

25.03

1.3

1.2

249.58

376.36

u/l

1.81

358

1181

Sequelae of external causes of morbidity and mortality

151

599

2.54

24.99

1.3

1.2

293.67

302.74

u/l

0.04

144

550

Asthma, unspecified (mode), excluding more controls

234

779

2.16

24.97

1.4

1.2

209.59

388.40

u/l

2.00

216

724

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

464

1802

1.72

24.88

1.3

1.2

280.44

325.84

u/l

0.46

429

1685

Diabetes mellitus

470

1576

1.73

24.84

1.3

1.2

200.34

344.54

u/l

4.07

428

1477

Diabetes, varying definitions

468

1576

1.73

24.73

1.3

1.2

200.79

344.38

u/l

4.04

426

1477

Behavioural syndromes associated with physiological disturbances and physical factors

443

1731

1.74

24.69

1.4

1.2

261.97

332.44

u/l

0.94

411

1621

All pneumoniae

470

1794

1.71

24.43

1.3

1.2

265.46

328.10

u/l

0.76

434

1679

Assault

263

3.38

24.36

1.5

1.3

396.38

353.41

u/l

0.13

243

Pneumonias (Asthma/COPD co-morbidities)

467

1791

1.71

24.35

1.3

1.2

265.79

328.32

u/l

0.76

432

1676

Recurrent or chronic depression

186

550

2.36

24.24

1.4

1.2

359.09

384.29

u/l

0.09

172

512

Other diseases of the digestive system

175

755

2.33

24.08

1.5

1.2

302.84

401.62

u/l

0.58

163

698

Other reaction to severe stress, and adjustment disorders

184

811

2.28

24.02

1.4

1.3

290.71

301.58

u/l

0.06

172

754

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

306

3.17

23.96

1.7

1.2

315.08

373.27

u/l

0.27

282

GI-bleeding

174

753

2.32

23.77

1.4

1.2

302.94

400.98

u/l

0.57

162

698

Schizophrenia or delusion, excluding more controls

140

542

2.56

23.66

1.3

1.2

245.96

380.85

u/l

0.83

132

498

Implicit bacterial Sepsis

214

860

2.14

23.37

1.3

1.2

278.43

373.52

u/l

0.62

192

798

Bleeding

389

1546

1.77

23.35

1.3

1.2

241.66

357.44

u/l

1.84

364

1429

Ischemic heart diseases

375

1239

1.81

23.31

1.3

1.2

274.68

376.07

u/l

1.15

341

1153

Selective serotonin reuptake inhibitors

433

1292

1.75

23.29

1.2

339.23

353.71

u/l

0.07

397

1209

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

431

1479

1.73

23.28

1.3

1.2

205.89

351.58

u/l

3.34

395

1383

Asthma, unspecified (mode)

240

839

2.07

23.19

1.4

1.2

209.40

373.19

u/l

1.94

221

781

Acute sinusitis

253

1156

2.00

23.16

1.2

1.3

261.92

341.33

u/l

0.74

235

1075

Alcoholic liver disease

200

3.70

23.11

1.8

1.3

369.24

413.66

u/l

0.14

189

Explicit Sepsis, including avohilmo

225

983

2.08

23.10

1.3

1.2

185.58

357.94

u/l

2.99

204

910

Type 2 diabetes, wide definition

336

1144

1.86

23.09

1.2

156.08

236.16

u/l

4.87

319

1079

Urinary track infection

264

643

2.06

23.04

1.4

1.2

195.15

299.32

u/l

1.25

244

598

Insomnia

416

1679

1.73

23.00

1.4

1.2

266.66

331.38

u/l

0.78

383

1573

Migraine with aura

128

488

2.64

22.97

1.3

344.87

275.45

u/l

0.35

119

458

Deforming dorsopathies

132

512

2.59

22.88

1.2

218.02

479.73

u/l

2.10

122

467

Condition for Implicit Sepsis (Organ dysfunction codes)

396

1574

1.75

22.75

1.2

1.3

274.70

337.84

u/l

0.67

362

1473

Pneumonia, organism unspecified

417

1664

1.72

22.74

1.3

273.13

333.57

u/l

0.61

386

1555

Asthma, hospital admissions , main diagnosis only

381

1904

1.74

22.71

1.4

1.2

214.85

338.24

u/l

3.03

362

1771

Sleep disorders

421

1693

1.72

22.71

1.4

1.2

264.00

335.18

u/l

0.90

389

1587

Depression medications

120

202

3.00

22.42

1.3

1.1

480.29

382.79

u/l

0.24

109

193

Syncope and collapse

200

773

2.17

22.42

1.2

403.63

364.58

u/l

0.15

182

713

Rheumatism, unspecified

223

3.48

22.42

1.5

1.2

523.52

255.63

u/l

0.35

208

Diseases of liver

186

850

2.20

22.36

1.5

1.2

487.21

345.96

u/l

0.36

170

787

Other nutritional deficiencies

324

1636

1.81

22.23

1.4

1.2

287.01

340.18

u/l

0.49

304

1525

Intracranial injury

276

1356

1.90

22.08

1.3

1.2

278.27

339.35

u/l

0.52

261

1246

Malignant neoplasm of pancreas

135

4.28

22.07

1.3

1.2

362.27

333.50

u/l

0.06

122

Explicit Sepsis

219

969

2.07

22.06

1.3

1.2

186.52

359.44

u/l

2.94

199

899

Malignant neoplasm of pancreas, including Hilmo

170

3.87

22.01

1.3

1.2

443.22

350.47

u/l

0.21

153

Osteopathies and chondropathies

280

1356

1.89

22.00

1.3

208.28

341.46

u/l

2.63

265

1245

Falls/tendency to fall

474

1418

1.68

21.97

1.4

1.2

263.23

352.08

u/l

1.09

442

1318

Convulsions, not elsewhere classified

116

425

2.71

21.95

1.4

1.2

253.16

488.51

u/l

1.17

100

388

Other pulmonary diagnosis

331

891

1.87

21.87

1.3

1.2

322.69

383.60

u/l

0.29

300

832

Fentanyl

166

3.88

21.82

1.3

1.2

207.49

318.90

u/l

1.04

154

Soft tissue disorders related to use, overuse and pressure

144

597

2.43

21.74

1.5

1.1

436.11

351.17

u/l

0.18

131

552

Asthma (diagnoses ohter than nonallergic)

402

1912

1.70

21.69

1.4

1.2

220.73

333.56

u/l

2.77

378

1782

Non-invasive ventilation

110

339

2.81

21.69

1.1

212.83

481.15

u/l

1.65

324

Type 2 diabetes, definitions combined, including avohilmo

427

1452

1.70

21.66

1.3

1.2

219.85

344.99

u/l

2.59

396

1358

Diabetes medication

470

1658

1.66

21.65

1.3

1.2

202.50

350.55

u/l

3.99

431

1553

Excluding asthma or asthma-COPD overlap

330

891

1.86

21.61

1.3

1.2

325.11

383.60

u/l

0.28

299

832

Hypertensive diseases (excluding secondary)

225

624

2.10

21.57

1.4

1.2

220.96

469.66

u/l

2.30

207

591

Gastric ulcer

301

3.04

21.34

1.5

1.1

292.22

369.46

u/l

0.26

281

Injuries to the thorax

233

1179

1.98

21.31

1.3

1.2

213.43

357.05

u/l

2.56

219

1084

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

201

585

2.17

21.30

1.3

1.2

217.45

477.58

u/l

2.29

187

553

Type 2 diabetes, strict (exclude DM1)

428

1474

1.69

21.26

1.3

1.2

200.61

350.36

u/l

3.95

396

1379

Migraine without aura

101

355

2.86

21.24

1.5

1.4

176.09

236.89

u/l

1.36

331

Bacterial Sepsis

232

959

2.01

21.23

1.3

1.2

271.72

359.58

u/l

0.64

209

888

Type 2 diabetes, definitions combined

425

1462

1.70

21.20

1.3

1.2

201.13

351.97

u/l

3.94

393

1367

COPD differential diagnosis

328

892

1.85

21.04

1.3

1.2

327.44

377.25

u/l

0.23

297

833

Other anxiety disorders

218

915

2.03

20.83

1.4

1.3

244.12

317.13

u/l

0.67

196

850

Other septicaemia, including avohilmo

195

873

2.11

20.79

1.3

1.2

181.23

387.82

u/l

3.31

178

807

ILD differential diagnosis

327

892

1.84

20.78

1.3

1.2

328.14

377.25

u/l

0.22

296

833

Antihypertensive medication - note that there are other indications

243

627

2.03

20.66

1.3

1.2

358.98

379.25

u/l

0.09

227

589

Obesity and other hyperalimentation

304

1589

1.80

20.62

1.4

1.2

274.06

330.03

u/l

0.54

287

1478

Obesity

303

1585

1.81

20.60

1.4

1.2

273.74

330.44

u/l

0.55

286

1476

Septicaemia

208

928

2.05

20.60

1.3

1.2

184.03

381.21

u/l

3.37

190

858

Other noninfective gastroenteritis and colitis

133

547

2.44

20.43

1.2

1.3

311.37

282.25

u/l

0.12

126

500

Diaphragmatic hernia

173

797

2.18

20.43

1.3

1.2

368.48

331.98

u/l

0.08

156

739

Other heart diseases, wide

409

1468

1.69

20.37

1.3

1.2

267.40

353.07

u/l

1.09

371

1378

Other disorders of urethra and urinary system

307

1179

1.82

20.19

1.3

1.2

291.37

333.83

u/l

0.19

283

1102

Other septicaemia

190

857

2.10

20.14

1.3

1.2

182.18

384.67

u/l

3.11

173

793

Superficial injury of head

133

557

2.40

19.64

1.5

1.2

268.99

320.60

u/l

0.25

123

508

Diabetes, insulin treatment (Kela reimbursement)

446

1625

1.64

19.64

1.3

1.2

212.13

354.55

u/l

3.18

409

1519

Asthma-related pneumonia

180

853

2.11

19.60

1.4

1.2

167.39

381.10

u/l

3.33

171

777

Cardiovascular diseases

243

651

1.99

19.59

1.3

289.44

406.49

u/l

0.89

224

618

Hernia of abdominal wall

226

1168

1.94

19.55

1.6

1.2

489.96

318.37

u/l

0.56

207

1077

Other diseases of urinary system

426

1444

1.66

19.54

1.4

1.2

267.67

341.63

u/l

0.53

391

1345

Heart failure, not strict

333

1277

1.76

19.50

1.3

1.2

252.12

360.70

u/l

1.17

309

1177

Asthma, hospital admissions 3, pneumonia

180

855

2.11

19.48

1.4

1.2

167.39

380.92

u/l

3.34

171

779

Asthma-related pneumonia or sepsis

180

855

2.11

19.48

1.4

1.2

167.39

380.92

u/l

3.34

171

779

Use of hypnotics and sedatives

472

1677

1.61

19.40

1.3

1.2

266.04

338.57

u/l

0.98

430

1577

Sleep disorders (combined)

475

1538

1.62

19.35

1.3

1.2

344.73

320.60

u/l

0.12

429

1442

Diseases of appendix

340

1776

1.72

19.29

1.4

1.2

232.10

343.33

u/l

2.16

317

1658

Polyarthropathies

294

1039

1.82

19.24

1.3

1.2

222.77

375.79

u/l

2.19

274

968

Asthma/COPD (KELA code 203)

421

1724

1.63

18.94

1.3

1.2

215.08

347.90

u/l

3.27

400

1603

Metabolic disorders

420

1535

1.64

18.91

1.3

1.2

270.58

326.55

u/l

0.67

379

1441

Oedema, not elsewhere classified

146

632

2.27

18.89

1.6

1.2

207.96

390.36

u/l

1.60

136

584

Dental pulpitis, including avohilmo

411

1601

1.65

18.89

1.4

1.2

279.63

343.79

u/l

0.77

388

1488

Other (not insulin) diabetes medications

433

1561

1.63

18.80

1.3

1.2

200.14

355.94

u/l

4.00

399

1460

Nonorganic sleeping disorders, excluding more controls

359

2.72

18.58

1.4

1.3

194.54

293.79

u/l

1.26

328

Fall on same level

500

1694

1.58

18.49

1.4

1.2

305.55

326.80

u/l

0.18

473

1573

Appendicitis, broad definition

335

1771

1.70

18.47

1.4

1.2

233.71

342.98

u/l

2.08

313

1654

Ovarian cyst

159

401

2.28

18.41

1.2

305.67

244.44

u/l

0.36

149

373

Other bacterial intestinal infections

370

2.67

18.09

1.2

206.52

319.63

u/l

1.45

344

Cardiovascular diseases (excluding rheumatic etc)

256

781

1.88

18.02

1.3

1.2

306.95

419.35

u/l

0.78

233

743

Abnormalities of heart beat

155

696

2.17

18.01

1.3

1.2

247.47

360.02

u/l

0.87

140

645

Hypermobility syndrome

4.54

18.00

1.4

1.2

178.65

321.20

u/l

0.66

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

304

1527

1.74

17.98

1.2

1.3

254.41

342.26

u/l

1.13

283

1415

Spondylolisthesis/Spondylolysis

288

2.90

17.96

1.2

185.00

420.22

u/l

2.13

261

Insulin medication

270

1247

1.80

17.95

1.4

1.2

213.18

365.70

u/l

2.47

244

1157

Bacterial infection, other or unspecified, including avohilmo

267

1214

1.81

17.90

1.2

246.88

339.61

u/l

1.27

247

1127

Appendectomy

294

1619

1.73

17.52

1.3

231.99

344.10

u/l

1.87

276

1511

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

430

1822

1.59

17.51

1.4

1.2

294.74

323.63

u/l

0.28

393

1706

Acute appendicitis

315

1724

1.70

17.44

1.4

1.2

233.99

346.14

u/l

2.04

294

1609

Endocrine, nutritional and metabolic diseases

329

959

1.74

17.39

1.3

1.2

283.03

366.44

u/l

0.69

297

913

Dermatitis

290

1643

1.73

17.30

1.2

1.3

297.94

328.75

u/l

0.23

267

1541

Acute tubulo-interstitial nephritis

284

1371

1.75

17.30

1.2

211.40

333.05

u/l

2.16

269

1276

Implicit viral Sepsis

109

444

2.47

17.22

1.3

157.83

446.47

u/l

2.44

411

Viral Sepsis

109

444

2.47

17.22

1.3

157.83

446.47

u/l

2.44

411

General examination and investigation of persons without complaint and reported diagnosis

296

867

1.78

17.08

1.3

1.2

284.32

368.49

u/l

0.66

278

817

Implicit viral Sepsis, including avohilmo

153

721

2.13

17.05

1.3

1.2

243.02

393.13

u/l

0.93

138

666

Oxicams

108

233

2.64

17.02

1.3

1.2

370.25

247.47

u/l

0.54

102

222

Bacterial infection, other or unspecified

242

1119

1.83

17.02

1.2

225.30

348.30

u/l

1.85

223

1042

Use of disulfiram, acamprosate or naltrexone

183

3.37

16.94

1.4

1.3

216.54

420.77

u/l

1.66

170

Haemorrhage from respiratory passages

145

590

2.18

16.90

1.1

1.2

166.53

417.33

u/l

3.86

137

547

Alcohol withdrawal state with delirium

136

3.80

16.90

1.5

1.2

277.87

421.09

u/l

0.71

129

Other joint disorders

364

1140

1.67

16.86

1.3

1.2

193.96

372.81

u/l

4.06

331

1065

Migraine with aura and triptan purchases

304

2.78

16.85

1.4

334.27

241.80

u/l

0.34

279

Dermatitis and eczema

485

1863

1.54

16.83

1.2

274.70

326.12

u/l

0.63

442

1749

Certain infectious and parasitic diseases, including avohilmo

286

803

1.79

16.72

1.3

1.2

301.02

305.34

u/l

0.02

258

754

Diseases of the musculoskeletal system and connective tissue

203

509

2.00

16.64

1.3

1.2

291.63

358.48

u/l

0.37

188

478

Biguanides

418

1589

1.59

16.60

1.2

224.91

352.55

u/l

2.50

386

1483

Hard cardiovascular diseases

352

1256

1.66

16.45

1.3

237.14

379.69

u/l

2.14

320

1167

Impingement syndrome of shoulder

113

479

2.37

16.38

1.2

357.12

380.53

u/l

0.07

107

444

Osteoporosis

130

534

2.25

16.38

1.2

172.14

295.95

u/l

2.30

125

484

Kela-code for severe mental illness

171

856

2.01

16.32

1.3

262.98

355.66

u/l

0.63

158

785

Benign neoplasm of colon, rectum, anus and anal canal

287

1417

1.72

16.28

1.2

358.61

334.56

u/l

0.07

258

1325

Radiculopathy

245

2.96

16.18

1.5

1.2

190.33

363.47

u/l

2.56

225

Open wound of head

243

1283

1.78

16.04

1.3

1.2

255.50

348.44

u/l

1.11

228

1179

Other disorders of lacrimal gland

176

897

1.97

15.98

1.3

211.90

309.92

u/l

1.80

165

826

Disorders of adult personality and behaviour

139

650

2.15

15.94

1.3

203.34

330.37

u/l

1.97

126

601

Finngen Rheumatological endpoints

405

1447

1.59

15.92

1.3

1.2

220.56

360.22

u/l

2.82

380

1351

Coronary atherosclerosis

271

973

1.76

15.91

1.3

1.2

249.54

375.59

u/l

1.36

245

900

Diseases of the skin and subcutaneous tissue

415

1310

1.59

15.91

1.3

1.2

224.48

362.81

u/l

2.48

363

1245

Ventral hernia

118

518

2.29

15.81

1.4

1.2

311.76

400.53

u/l

0.38

108

476

Acute appendicitis, no complications

252

1434

1.75

15.78

1.4

1.2

231.53

341.55

u/l

1.71

236

1341

Personality disorders

132

608

2.18

15.74

1.4

1.3

260.31

338.68

u/l

0.48

121

562

Abnormal findings on diagnostic imaging of other body structures

305

2.71

15.66

1.3

277.95

302.08

u/l

0.09

278

Insulin, combination of fast acting with intermediate-acting or long-acting

270

1428

1.72

15.60

1.4

1.2

213.18

351.43

u/l

2.37

244

1325

Insulin, intermediate and long-acting

245

1347

1.76

15.53

1.4

1.2

190.08

352.67

u/l

3.80

220

1248

Other bacterial intestinal infections, including avohilmo

117

516

2.28

15.51

1.2

1.3

280.67

335.79

u/l

0.27

111

481

Mycoses, including avohilmo

401

1955

1.56

15.51

1.3

1.2

384.02

301.98

u/l

0.35

372

1828

Erysipelas, including avohilmo

316

1414

1.66

15.48

1.3

1.2

282.58

365.63

u/l

0.71

291

1321

Other arthrosis

236

876

1.81

15.39

1.2

317.45

397.58

u/l

0.50

223

818

Duodenal ulcer

160

3.40

15.30

1.2

1.1

292.00

308.33

u/l

0.06

150

Candidiasis

281

2.76

15.26

1.5

1.2

210.82

335.45

u/l

1.12

260

Obesity due to excess calories

221

1233

1.80

15.18

1.3

1.2

256.12

337.95

u/l

0.84

206

1140

Diseases of salivary glands

156

777

2.02

15.15

1.3

1.2

214.68

325.46

u/l

1.81

138

712

Other systemic involvement of connective tissue (FG)

120

530

2.23

15.11

1.5

1.2

272.59

387.94

u/l

0.51

113

483

Hypertension, essential

316

1071

1.67

15.08

1.4

1.2

222.12

403.23

u/l

2.85

289

1007

Arthropathies

365

1141

1.62

15.04

1.2

199.63

372.51

u/l

3.84

338

1066

Disorders of lacrimal system

204

1095

1.84

15.02

1.3

323.30

355.73

u/l

0.10

191

1014

Phobic anxiety disorders

239

2.90

14.98

1.2

274.89

308.18

u/l

0.20

224

Heart failure and coronary heart disease

175

624

1.97

14.90

1.2

241.75

446.88

u/l

1.49

169

579

Diseases of pulp and periapical tissues, including avohilmo

421

1399

1.56

14.90

1.3

1.2

298.63

345.01

u/l

0.40

388

1302

Hypertensive diseases

322

1099

1.66

14.84

1.3

1.2

244.39

398.55

u/l

2.05

294

1033

Hypertension

321

1095

1.66

14.82

1.3

1.2

244.08

399.20

u/l

2.06

293

1030

Irregular menses

211

865

1.84

14.80

1.2

1.3

206.87

264.83

u/l

0.76

201

808

Iron deficiency anaemia

195

1034

1.86

14.79

1.4

1.2

196.04

331.80

u/l

2.32

181

950

Other and unspecified dermatitis

239

1375

1.74

14.77

1.2

1.3

286.46

336.94

u/l

0.38

217

1285

Unspecified mental disorder

183

972

1.89

14.72

1.3

252.92

340.72

u/l

0.66

169

889

Early onset COPD, excluding more controls

379

2.46

14.72

1.5

1.3

218.73

469.33

u/l

1.52

354

Other heart diseases

189

642

1.92

14.69

1.4

1.2

280.18

460.73

u/l

1.25

174

607

Obesity related asthma

167

865

1.94

14.52

1.3

243.18

398.89

u/l

1.46

158

793

Trochanteric bursitis

273

2.73

14.39

1.6

1.2

493.34

264.53

u/l

0.30

254

Other arrhythmias

279

1243

1.68

14.38

1.3

1.2

229.32

360.73

u/l

1.82

256

1160

Emotionally unstable personality disorder

246

2.83

14.32

1.5

1.3

159.45

325.63

u/l

2.29

228

Problems related to lifestyle

219

2.95

14.31

1.6

1.2

283.98

391.83

u/l

0.64

211

Transport accidents

200

910

1.83

14.25

1.2

225.14

308.28

u/l

1.04

187

845

Hypertensive Heart Disease

110

363

2.31

14.24

1.2

1.1

189.63

497.14

u/l

1.93

103

341

Autoimmune diseases related-to ILD

365

1958

1.56

14.20

1.3

1.2

267.01

326.69

u/l

0.78

335

1834

Nutritional anaemias

218

1178

1.77

14.10

1.3

1.2

210.06

335.88

u/l

2.03

202

1087

Chronic apical periodontitis

464

1744

1.49

13.81

1.3

1.2

286.15

327.05

u/l

0.40

433

1626

Other acute lower respiratory infections

236

1314

1.71

13.70

1.3

227.35

346.21

u/l

1.43

219

1208

Heart failure and antihypertensive medication

102

279

2.38

13.68

1.4

1.1

198.74

526.63

u/l

1.67

261

Specific personality disorders

113

519

2.19

13.64

1.4

1.3

206.74

344.14

u/l

1.70

102

479

Cutaneous abscess, furuncle and carbuncle

129

625

2.07

13.58

1.4

1.2

160.19

356.13

u/l

4.28

118

571

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

387

1977

1.53

13.55

1.3

1.2

366.86

305.54

u/l

0.26

358

1848

Hypertensive heart and/or renal disease

118

394

2.20

13.51

1.3

1.2

185.35

487.89

u/l

2.12

110

369

Hypokalaemia

254

2.74

13.51

2.1

1.2

340.19

327.59

u/l

0.03

238

Fracture of rib(s), sternum and thoracic spine

148

755

1.97

13.50

1.4

1.2

198.05

409.88

u/l

2.69

139

694

Bipolar affective disorders

386

2.37

13.28

1.4

1.2

268.69

352.26

u/l

0.37

358

Other and unspecified effects of external causes

129

631

2.05

13.24

1.5

1.2

310.22

282.85

u/l

0.15

118

576

Injuries to the knee and lower leg

493

1822

1.46

13.23

1.3

1.2

274.23

328.57

u/l

0.62

467

1695

Complications of medical and surgical care

315

1794

1.58

13.20

1.3

194.31

333.22

u/l

3.85

286

1679

Bacterial pneumoniae

181

867

1.84

13.16

1.3

1.2

227.35

355.02

u/l

1.44

173

800

Ischaemic heart disease, wide definition

318

1227

1.60

13.06

1.3

1.2

264.84

379.95

u/l

1.28

289

1140

Other enthesopathies

131

648

2.03

13.03

1.3

1.2

443.69

346.86

u/l

0.18

120

603

Symptoms and signs involving the skin and subcutaneous tissue

310

1860

1.58

12.95

1.4

1.2

214.42

331.79

u/l

2.70

289

1735

Major coronary heart disease event excluding revascularizations

240

929

1.71

12.93

1.2

229.82

375.40

u/l

1.64

227

858

Unstable angina pectoris

151

610

1.95

12.89

1.2

213.10

449.75

u/l

1.81

144

562

Somatoform disorder

337

2.45

12.85

1.3

1.2

201.01

298.19

u/l

1.33

311

Pruritus

233

2.77

12.82

1.1

1.3

211.48

259.80

u/l

0.44

215

Polycystic ovarian syndrome, consortium definition

290

1021

1.63

12.80

1.2

1.3

201.68

261.05

u/l

0.94

272

952

Sleep apnoea, including avohilmo

413

1668

1.50

12.75

1.2

351.74

303.06

u/l

0.22

382

1561

Migraine without aura and triptan purchases

316

2.48

12.60

1.6

1.4

175.59

240.72

u/l

1.21

291

Benign neoplasm: Colon

236

1327

1.67

12.54

1.2

385.63

319.58

u/l

0.19

216

1237

Any reimbursement code in KELA

218

618

1.77

12.53

1.4

1.1

264.61

429.86

u/l

1.31

203

579

Schizophrenia or delusion

140

724

1.94

12.32

1.3

245.96

332.44

u/l

0.67

132

662

Other complications of surgical and medical care, not elsewhere classified

179

2.98

12.19

1.4

1.2

341.54

269.30

u/l

0.22

166

Fall on same level involving ice and snow

250

1539

1.63

12.06

1.5

1.2

249.62

321.13

u/l

0.64

232

1422

Exposure to other specified factors

340

1919

1.52

12.06

1.5

1.2

394.41

304.11

u/l

0.44

320

1790

Infections of the skin and subcutaneous tissue

256

1560

1.62

12.04

1.3

195.05

347.70

u/l

3.87

237

1449

Other neurological diseases

299

1477

1.57

12.03

1.2

1.3

238.91

331.25

u/l

1.47

278

1368

Schizophrenia, schizotypal and delusional disorders

140

731

1.92

11.99

1.3

245.96

332.39

u/l

0.67

132

668

Disorders of eyelid, lacrimal system and orbit

363

1767

1.51

11.96

1.3

268.98

319.22

u/l

0.29

338

1647

Bacterial pneumonia, not elsewhere classified

169

818

1.82

11.94

1.3

232.93

362.36

u/l

1.35

162

757

Abnormal involuntary movements

283

2.53

11.91

1.1

1.2

213.29

327.78

u/l

0.93

260

Other and unspecified iron deficiency

153

823

1.86

11.88

1.4

1.2

194.09

346.53

u/l

2.05

144

752

Accidents

313

996

1.58

11.71

1.3

1.2

304.94

304.69

u/l

0.00

292

925

Malignant neoplasm of digestive organs, including Hilmo

189

791

1.76

11.63

1.3

1.2

305.08

368.11

u/l

0.35

176

729

Conductive and sensorineural hearing loss

325

1404

1.54

11.61

1.3

1.2

373.06

331.43

u/l

0.15

302

1300

ILD medications: immunosuppressive drugs

260

1476

1.60

11.51

1.3

1.2

230.92

329.98

u/l

1.85

239

1375

Presence of cardiac and vascular implants and grafts

189

794

1.76

11.50

1.3

1.2

187.31

407.44

u/l

2.98

178

734

Diseases of arteries, arterioles and capillaries (FINNGEN)

302

2.22

11.38

1.3

1.2

365.84

611.18

u/l

0.74

285

Other medical care

221

1117

1.66

11.36

1.2

333.96

303.23

u/l

0.17

205

1039

Chronic gastritis

107

519

2.07

11.31

1.2

1.1

201.03

390.51

u/l

1.43

484

Other disorders of ear

376

1640

1.48

11.25

1.3

1.2

352.81

318.58

u/l

0.15

355

1522

Other diseases of upper respiratory tract

439

1580

1.45

11.19

1.2

1.3

340.05

308.77

u/l

0.19

396

1482

Bacterial pneumonia (organism specified)

191

1011

1.72

11.13

1.3

1.2

230.85

360.34

u/l

1.70

182

931

Dipeptidyl peptidase 4 (DPP-4) inhibitors

228

1091

1.64

11.03

1.2

199.21

372.75

u/l

2.67

212

1014

Gonarthrosis

256

896

1.62

10.95

1.3

1.2

177.40

394.36

u/l

3.98

241

839

Heart failure,strict

211

878

1.68

10.93

1.3

1.2

221.31

364.82

u/l

1.35

200

807

Inflammatory diseases of female pelvic organs

250

1066

1.61

10.86

1.2

1.3

241.80

249.94

u/l

0.06

228

1003

Maltreatment syndromes

3.75

10.85

1.9

1.2

264.61

394.93

u/l

0.46

Carpal tunnel syndrome

251

1371

1.59

10.82

1.2

337.12

328.74

u/l

0.03

237

1277

Autoimmune diseases excluding thyroid diseases

422

1582

1.45

10.80

1.4

1.2

300.75

327.23

u/l

0.13

389

1487

Sensorineural hearing loss

305

1327

1.53

10.80

1.3

1.2

388.40

333.60

u/l

0.20

282

1231

Other external causes of accidental injury

308

996

1.55

10.80

1.3

1.2

305.43

304.69

u/l

0.00

287

925

Other and unspecified nonorganic psychotic disorders

418

2.16

10.68

1.4

1.3

294.84

364.92

u/l

0.28

385

Other postsurgical states

129

3.21

10.68

1.3

1.2

259.67

343.03

u/l

0.31

117

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

161

2.94

10.59

1.6

1.3

296.35

351.90

u/l

0.20

149

Artrosis, including avohilmo

322

1161

1.52

10.53

1.3

295.79

342.54

u/l

0.27

301

1079

Injuries to the ankle and foot

302

1705

1.52

10.52

1.3

1.2

226.24

329.31

u/l

1.75

282

1592

Mycoses

126

665

1.90

10.52

1.4

1.2

251.19

418.64

u/l

1.30

116

612

Obesity, other/unspecified

147

815

1.81

10.50

1.5

1.2

264.12

328.83

u/l

0.42

139

751

Medical observation and evaluation for suspected diseases and conditions

269

867

1.59

10.49

1.3

1.2

203.07

368.49

u/l

2.65

235

817

Gout

119

525

1.95

10.45

1.3

1.2

202.62

492.81

u/l

2.19

113

485

COPD (mode)

121

485

1.95

10.43

1.4

1.2

231.68

402.84

u/l

1.23

112

453

Tongue abnormality

116

3.31

10.40

1.2

1.3

242.77

351.08

u/l

0.36

106

Neoplasms

298

1013

1.55

10.40

1.2

1.3

344.86

318.18

u/l

0.17

280

949

Diseases of the ear and mastoid process

453

1599

1.42

10.37

1.3

1.2

328.32

322.79

u/l

0.03

421

1493

Polyneuropathies and other disorders of the peripheral nervous system

463

2.08

10.36

1.2

259.64

457.22

u/l

0.97

424

Diseases of the respiratory system

235

720

1.64

10.33

1.3

1.2

286.73

349.34

u/l

0.37

215

675

Inflammatory bowel disease

139

763

1.83

10.27

1.3

271.08

373.37

u/l

0.74

125

698

Visual disturbances

209

1285

1.63

10.26

1.3

1.2

179.01

341.62

u/l

3.94

192

1189

Injuries to the shoulder and upper arm

352

1856

1.47

10.26

1.4

1.2

293.76

326.40

u/l

0.28

331

1725

Other diseases of anus and rectum

108

544

1.98

10.22

1.3

1.2

211.66

405.99

u/l

2.08

100

499

Panic disorder

280

2.40

10.21

1.5

1.2

229.75

308.74

u/l

0.82

260

Cerebrovascular diseases (FINNGEN)

118

422

1.97

10.17

1.5

1.1

202.70

562.73

u/l

2.32

109

399

Genitourinary diseases

221

670

1.66

10.16

1.2

334.00

389.05

u/l

0.37

206

616

Extrapyramidal and movement disorders

161

927

1.74

10.13

1.3

1.2

258.44

333.45

u/l

0.45

148

853

Other systemic involvement of connective tissue

121

639

1.90

10.10

1.5

1.2

272.58

270.37

u/l

0.01

114

585

Arthrosis

275

968

1.56

10.09

1.3

1.2

220.49

385.33

u/l

2.47

257

900

Other CVD (FINNGEN)

152

2.72

9.97

1.5

1.1

246.09

731.70

u/l

1.02

143

Injuries to the abdomen, lower back, lumbar spine and pelvis

176

1028

1.69

9.95

1.4

1.2

325.22

363.36

u/l

0.19

167

935

Urticaria and erythema

151

861

1.76

9.83

1.3

211.87

304.55

u/l

1.05

132

793

Other specified/unspecified arthritis

114

597

1.92

9.78

1.2

1.3

316.62

459.67

u/l

0.58

105

556

Inflammatory disease of uterus

268

2.40

9.74

1.1

1.2

360.16

222.09

u/l

0.41

246

Angina pectoris

213

870

1.63

9.72

1.2

243.91

380.91

u/l

1.23

196

806

Injuries to the wrist and hand

407

1906

1.42

9.72

1.4

1.2

440.79

287.33

u/l

0.81

386

1774

Disorders of vestibular function (Vertigo)

197

1179

1.63

9.68

1.2

191.04

342.18

u/l

2.78

185

1091

Caries of dentine

425

2.07

9.66

1.1

1.2

240.74

339.25

u/l

0.88

405

Erysipelas

225

1226

1.59

9.65

1.3

1.2

293.79

350.72

u/l

0.33

207

1139

Nonorganic sleeping disorders

483

2.02

9.63

1.4

1.3

194.54

301.63

u/l

1.47

443

Volume depletion

170

2.78

9.62

1.2

169.05

319.56

u/l

1.53

161

Disturbances of skin sensation

119

636

1.88

9.60

1.2

253.79

336.44

u/l

0.75

111

587

Gonarthrosis [arthrosis of knee](FG)

299

1142

1.51

9.59

1.3

1.2

212.79

385.22

u/l

2.83

280

1065

Fissure and fistula of anal and rectal regions

417

2.09

9.57

1.3

1.2

233.82

476.16

u/l

1.95

381

Other symptoms and signs involving cognitive functions and awareness

186

998

1.66

9.56

1.1

1.2

241.72

353.49

u/l

0.89

169

928

Any death

261

1189

1.54

9.49

1.3

1.2

326.83

351.64

u/l

0.15

242

1095

Autoimmune diseases excluding thyroid diseases, strict definition

404

1547

1.42

9.49

1.3

1.2

304.77

330.89

u/l

0.12

374

1452

Symptoms and signs involving the urinary system

310

1584

1.48

9.46

1.4

1.2

232.24

332.43

u/l

1.66

290

1465

Diplopia

266

2.38

9.43

1.3

1.2

162.12

326.02

u/l

2.31

246

Systemic connective tissue disorders

143

815

1.76

9.36

1.4

1.2

262.35

264.09

u/l

0.01

133

748

Viral infections characterized by skin and mucous membrane lesions

179

1085

1.65

9.32

1.5

1.2

383.20

336.12

u/l

0.14

168

992

Heart failure, strict

232

1028

1.57

9.27

1.3

1.2

211.15

363.68

u/l

1.76

221

943

Acute renal failure

490

1.99

9.27

1.3

1.2

215.52

460.08

u/l

1.96

453

Hypothyroidism, levothyroxine purchases

196

2.26

9.26

1.3

1.1

312.89

384.49

u/l

0.17

187

Hypothyroidism and >3 levothyroxin purchases

196

2.26

9.26

1.3

1.1

312.89

384.49

u/l

0.17

187

Visual disturbances and blindness

218

1390

1.57

9.21

1.3

1.2

178.70

338.57

u/l

4.20

200

1285

External causes of morbidity and mortality

234

739

1.59

9.18

1.4

1.2

327.39

308.21

u/l

0.10

222

687

All-cause Heart Failure

228

1011

1.57

9.13

1.3

1.2

210.43

367.13

u/l

1.78

217

926

COPD

176

862

1.66

9.08

1.4

1.2

212.17

401.04

u/l

2.62

164

799

Lesion of ulnar nerve

296

2.28

9.06

1.4

1.2

411.56

441.74

u/l

0.08

275

Other and unspecified polyneuropathies, also in other diseases

400

2.09

9.04

1.2

279.56

397.68

u/l

0.51

369

Benign neoplasm of other and ill-defined parts of digestive system

387

2.10

9.03

1.4

1.2

185.22

293.47

u/l

1.48

353

Other and unspecified tonsillitis

131

607

1.80

8.97

1.3

360.46

356.37

u/l

0.02

125

562

Viral and other specified intestinal infections, including avohilmo

113

584

1.87

8.95

1.3

1.2

255.96

292.33

u/l

0.22

104

545

Other extrapyramidal and movement disorders in other diseases

107

567

1.90

8.91

1.2

186.48

282.48

u/l

1.60

519

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

387

1738

1.41

8.90

1.3

1.2

240.94

343.82

u/l

1.68

359

1627

Abnormal findings on examination of blood, without diagnosis

194

1096

1.61

8.88

1.2

413.16

328.69

u/l

0.27

187

1006

Chronic laryngitis and laryngotracheitis

286

2.29

8.88

1.2

222.07

265.35

u/l

0.23

263

Hypothyroidism (congenital or acquired)

196

2.23

8.88

1.3

1.1

315.49

384.49

u/l

0.17

187

Retention of urine

143

663

1.75

8.88

1.4

1.2

241.32

424.85

u/l

1.37

133

615

Ulcerative colitis, NAS

280

2.30

8.86

1.5

1.3

337.67

337.49

u/l

0.00

259

Injury, poisoning and certain other consequences of external causes

186

560

1.67

8.83

1.3

1.2

310.08

336.08

u/l

0.11

175

515

Viral and other specified intestinal infections

400

2.06

8.81

1.3

271.09

311.45

u/l

0.18

372

Unspecified acute lower respiratory infection

339

2.16

8.76

1.2

180.10

437.49

u/l

2.89

317

Used for control exclusion in common control thyroid runs

411

1483

1.40

8.72

1.3

1.2

397.70

310.67

u/l

0.38

370

1391

Disorders of synovium and tendon

197

1051

1.59

8.66

1.3

1.2

409.64

300.98

u/l

0.32

176

980

Dislocation, sprain and strain of joints and ligaments of knee

246

1474

1.51

8.65

1.4

1.2

232.94

334.08

u/l

1.56

231

1371

Dental caries

486

1.93

8.62

1.2

232.97

319.75

u/l

0.86

464

Venous thromboembolism

215

1337

1.55

8.61

1.2

207.60

338.16

u/l

2.71

201

1235

Malignant neoplasm of digestive organs

162

740

1.68

8.61

1.3

1.2

288.34

378.64

u/l

0.56

150

679

Other hearing loss

111

584

1.85

8.52

1.2

328.51

335.21

u/l

0.02

105

533

Inguinal hernia

225

967

1.55

8.44

1.2

1.3

346.71

369.28

u/l

0.06

206

894

Autoimmune diseases

430

1586

1.38

8.36

1.3

1.2

332.38

326.76

u/l

0.02

386

1490

Disorders of skin appendages

203

1300

1.56

8.30

1.3

267.65

343.98

u/l

0.89

187

1203

Effects of foreign body entering through natural orifice

107

583

1.84

8.21

1.4

1.2

215.29

428.30

u/l

2.14

102

527

Gout, FINNGEN

119

665

1.78

8.20

1.3

1.2

202.62

449.82

u/l

2.17

113

620

Other arthritis (FG)

127

729

1.75

8.18

1.3

1.2

308.60

419.35

u/l

0.49

117

671

All influenza

109

598

1.83

8.17

1.2

1.3

228.29

429.31

u/l

1.69

100

553

Atrial fibrillation and flutter with reimbursement

309

1.96

8.16

1.3

1.1

247.65

646.44

u/l

1.65

291

Statin medication

250

935

1.51

8.05

1.3

1.2

223.92

324.43

u/l

1.70

232

873

Benign neoplasms

378

1477

1.39

8.04

1.2

434.96

317.12

u/l

0.62

346

1393

Adverse effects, not elsewhere classified

426

1.98

8.01

1.5

1.2

223.17

269.48

u/l

0.38

395

Acute bronchitis

166

1010

1.62

7.96

1.4

1.2

235.08

366.63

u/l

1.06

155

920

Unspecified fall

207

1327

1.53

7.94

1.3

207.88

337.47

u/l

2.00

198

1215

Abnormal findings on diagnostic imaging of lung

187

1130

1.57

7.93

1.1

1.2

220.23

349.61

u/l

1.85

175

1047

Toxic effects of substances chiefly nonmedicinal as to source

225

2.37

7.91

1.4

1.3

368.96

353.58

u/l

0.03

209

Second line medication for Crohn's disease

230

1540

1.49

7.83

1.5

1.2

237.14

341.54

u/l

1.65

214

1432

Zoster [herpes zoster], including avohilmo

210

1333

1.52

7.79

1.2

323.75

298.42

u/l

0.06

197

1236

173

2.56

7.74

1.1

1.2

444.87

464.01

u/l

0.04

160

Other chronic obstructive pulmonary disease, including avohilmo

209

1124

1.53

7.73

1.4

1.2

216.47

360.72

u/l

2.41

192

1048

COPD related to multimorbidity

155

802

1.64

7.68

1.4

1.2

195.75

376.63

u/l

2.66

143

742

Urticaria

119

684

1.74

7.66

1.3

234.90

295.06

u/l

0.49

105

631

Diseases of peritoneum

180

2.52

7.64

1.1

1.3

281.11

348.40

u/l

0.30

168

Other and unspecified injuries of lower leg

134

2.78

7.63

1.7

1.2

191.11

292.57

u/l

1.22

123

Generalized anxiety disorder

312

2.12

7.59

1.5

1.2

267.75

270.40

u/l

0.02

294

Abnormal serum enzyme levels

125

704

1.72

7.58

1.2

517.04

399.67

u/l

0.24

120

651

Insulin, fast-acting

143

866

1.65

7.58

1.5

1.2

169.98

394.50

u/l

3.45

124

797

Liquid cancers, including Hilmo

142

754

1.66

7.55

1.3

1.2

229.44

387.90

u/l

1.86

135

693

Atrial fibrillation and flutter

111

396

1.81

7.52

1.3

1.2

265.66

600.54

u/l

1.73

105

375

Other chronic obstructive pulmonary disease

164

837

1.61

7.51

1.4

1.2

208.94

406.74

u/l

2.69

152

777

Crohn disease

262

2.23

7.51

1.2

1.3

374.10

345.48

u/l

0.08

241

Umbilical hernia

110

622

1.77

7.51

1.7

1.3

683.57

417.11

u/l

0.41

102

571

DVT of lower extremities and pulmonary embolism

164

1026

1.60

7.51

1.2

209.71

363.03

u/l

2.38

153

943

Other anaemias

169

999

1.59

7.50

1.5

1.2

288.87

361.95

u/l

0.44

154

920

Epilepsy

118

679

1.74

7.49

1.1

1.2

333.34

370.85

u/l

0.16

105

623

Sleep apnoea

366

1678

1.38

7.45

1.2

314.00

314.10

u/l

0.00

337

1570

Conjunctivitis (acute, non atopic)

119

687

1.73

7.44

1.3

1.2

202.04

335.61

u/l

2.32

112

626

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

240

1609

1.46

7.40

1.2

1.3

175.46

343.70

u/l

4.80

223

1500

Other diseases of liver

405

1.96

7.34

1.3

384.83

320.01

u/l

0.22

373

Other and unspecified anaemias

167

995

1.58

7.27

1.5

1.2

292.00

362.12

u/l

0.41

152

916

Other and unspecified drugs and medicaments

167

2.53

7.24

1.5

1.3

312.51

305.84

u/l

0.02

152

Excessive, frequent and irregular menstruation

133

414

1.72

7.24

1.2

263.84

241.08

u/l

0.10

124

385

All chronic kidney diseases

205

1082

1.51

7.21

1.3

1.2

199.74

373.70

u/l

2.44

185

994

Diseases of the eye and adnexa

298

1047

1.43

7.19

1.4

1.2

251.33

399.68

u/l

2.15

277

984

Early onset COPD

507

1.84

7.19

1.5

1.2

218.73

483.95

u/l

2.01

465

Vasomotor and allergic rhinitis

146

884

1.62

7.09

1.2

1.3

257.08

266.59

u/l

0.10

131

822

Ulcerative colitis

100

560

1.79

7.08

1.4

1.3

284.32

348.64

u/l

0.34

511

Necrosis of pulp, including avohilmo

232

1576

1.46

7.00

1.4

1.2

188.68

339.62

u/l

4.53

220

1466

Dissociative [conversion] disorders

3.52

7.00

1.3

1.2

162.26

266.83

u/l

0.71

Oter anti-inflammatory and antirheumatic agents, non-steroids

209

2.03

6.99

1.2

182.34

243.64

u/l

1.23

201

Renal failure

183

1017

1.54

6.98

1.2

209.25

382.82

u/l

2.16

162

943

Aplastic and other anaemias

178

1059

1.54

6.97

1.5

1.2

283.09

353.43

u/l

0.45

163

976

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

199

1280

1.50

6.96

1.3

225.39

318.57

u/l

1.41

179

1200

Paroxysmal tachycardia

351

1.92

6.94

1.3

1.2

356.79

524.06

u/l

0.51

330

STROKE

200

889

1.52

6.94

1.2

220.38

408.02

u/l

2.28

182

831

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

164

910

1.57

6.85

1.3

193.70

260.91

u/l

0.90

159

849

ILD medications: azathioprine

296

2.07

6.64

1.4

1.2

224.75

319.47

u/l

0.96

270

Other and unspecified nerve root and plexus disorders, also in other diseases

449

1.86

6.61

1.4

1.2

250.24

379.57

u/l

1.05

414

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

123

745

1.66

6.61

1.4

1.3

176.03

432.05

u/l

3.76

115

686

Glucagon-like peptide-1 (GLP-1) analogues

123

745

1.66

6.61

1.4

1.3

176.03

432.05

u/l

3.76

115

686

Iron deficiency anaemia secondary to blood loss (chronic)

317

2.03

6.60

1.3

1.2

207.43

312.33

u/l

1.05

293

Blepharochalasis

113

673

1.68

6.48

1.1

1.2

217.40

280.65

u/l

0.47

103

618

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

147

924

1.57

6.43

1.4

1.3

212.43

321.07

u/l

2.20

139

850

Anorexia (incl.atypical)

2.98

6.37

1.6

1.2

221.00

359.48

u/l

0.58

Azathioprine

301

2.04

6.37

1.4

1.3

224.75

323.10

u/l

1.03

275

Disease of hard tissues of teeth, NOS

190

656

1.52

6.35

1.3

1.2

419.43

294.78

u/l

0.42

176

629

Other special examinations and investigations of persons without complaint or reported diagnosis

246

867

1.44

6.27

1.3

1.2

358.64

368.49

u/l

0.03

221

817

All influenza (not pneumonia)

303

2.02

6.26

1.2

306.83

370.06

u/l

0.37

281

Disorders of oesophagus in diseases classified elsewhere

7.10

6.23

2.9

1.1

228.96

322.80

u/l

0.23

Pulmonary heart disease

115

696

1.66

6.22

1.2

213.16

391.33

u/l

1.96

106

636

Insulin, fast-acting or short human

143

913

1.57

6.20

1.5

1.2

169.98

385.24

u/l

3.46

124

842

Primary gonarthrosis, bilateral

201

1150

1.47

6.18

1.3

1.2

248.55

373.02

u/l

1.08

188

1070

Benign paroxysmal vertigo

114

690

1.66

6.17

1.2

158.03

295.81

u/l

4.30

108

638

Pulmonary embolism

115

698

1.65

6.15

1.2

213.16

391.01

u/l

1.96

106

637

Pure hypercholesterolaemia

282

1292

1.39

6.13

1.2

301.77

344.86

u/l

0.18

257

1212

Persistent mood disorders

403

1.87

6.13

1.3

1.2

359.96

343.60

u/l

0.04

373

Paracetamol or NSAID medication

106

2.34

6.12

1.2

426.61

239.36

u/l

0.43

Caries of dentine, including avohilmo

279

1021

1.40

6.10

1.3

1.2

323.89

347.16

u/l

0.13

256

958

Allergic rhinitis

116

699

1.64

6.07

1.2

1.3

269.12

315.25

u/l

0.41

106

647

Chronic rhinitis, nasopharyngitis and pharyngitis

125

779

1.61

6.03

1.2

1.3

241.55

347.76

u/l

1.01

115

721

Dental caries, including avohilmo

254

918

1.42

6.02

1.3

1.2

335.72

355.32

u/l

0.09

231

863

Other cataract

165

807

1.52

6.00

1.2

181.70

394.61

u/l

3.03

156

750

Diseases of inner ear

209

1392

1.44

5.96

1.3

1.2

194.54

329.49

u/l

2.89

195

1290

Menorrhagia

115

382

1.68

5.95

1.1

1.2

164.02

245.26

u/l

1.37

108

355

Striking against or struck by other objects

132

835

1.58

5.95

1.6

1.3

210.11

409.79

u/l

2.85

123

760

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

219

1537

1.42

5.93

1.2

1.3

171.80

335.87

u/l

5.05

205

1423

Pregnancy hypertension

148

859

1.54

5.89

1.3

204.28

231.11

u/l

0.34

143

800

Triptan medication for migraine, single purchase ok

276

1357

1.38

5.88

1.3

1.2

268.03

316.77

u/l

0.47

257

1261

Migraine, single triptan purchase ok & required. ICD-code if available is included

276

1357

1.38

5.88

1.3

1.2

268.03

316.77

u/l

0.47

257

1261

Congenital malformations of the musculoskeletal system, not elsewhere classified, including avohilmo

5.43

5.87

1.1

1.2

250.31

705.12

u/l

0.60

Herpesviral [herpes simplex] infections, including avohilmo

588

1.69

5.79

1.3

191.94

273.85

u/l

1.81

544

Open wound of wrist and hand

168

1093

1.49

5.72

1.6

1.3

544.07

333.59

u/l

0.57

161

1007

Restless leg syndrome

300

1.98

5.71

1.1

1.2

173.43

321.68

u/l

2.13

273

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

361

1731

1.32

5.70

1.3

1.2

259.16

330.52

u/l

0.87

337

1614

Follicular cysts of skin and subcutaneous tissue

399

1.84

5.69

1.3

1.2

308.91

389.89

u/l

0.39

368

Coxarthrosis

181

789

1.48

5.69

1.2

254.53

396.36

u/l

1.25

167

737

Internal derangement of knee

135

861

1.56

5.67

1.6

1.2

227.66

409.70

u/l

2.12

129

803

Pulmonary heart disease, diseases of pulmonary circulation

122

768

1.59

5.67

1.2

206.19

381.52

u/l

2.21

113

703

Other diseases of peritoneum

3.05

5.65

1.2

1.3

251.61

375.66

u/l

0.37

Dislocation, sprain and strain of joints and ligaments of head

3.21

5.60

1.2

211.71

291.64

u/l

0.52

Dentofacial anomalies [including malocclusion]

262

1497

1.37

5.53

1.4

1.2

287.88

324.11

u/l

0.25

240

1399

Conduction disorders

107

522

1.65

5.51

1.3

1.2

258.08

431.51

u/l

1.19

482

L04AX Other immunosuppressants

212

1506

1.41

5.46

1.3

239.02

336.83

u/l

1.43

196

1401

Benign neoplasm: Caecum

204

2.17

5.46

1.2

168.78

322.30

u/l

1.58

188

Myocardial infarction

167

786

1.49

5.42

1.2

294.64

398.06

u/l

0.57

161

726

Transplanted organ and tissue status

199

2.17

5.36

1.3

135.05

369.55

u/l

2.75

183

Other specified and unspecified personality disorders

161

2.31

5.34

1.8

1.3

165.31

393.36

u/l

1.78

151

Purpura and other haemorrhagic conditions

253

2.02

5.31

1.4

1.2

204.11

364.44

u/l

1.58

235

Other/unspecified synovitis and tenosynovitis

200

2.16

5.30

1.6

1.2

235.79

340.84

u/l

0.49

185

COPD, early/later onset

165

942

1.47

5.27

1.4

1.2

208.45

387.59

u/l

2.69

153

873

Enteropathic arthropathies

5.06

5.26

1.5

1.3

268.66

639.56

u/l

0.47

Transient ischemic attack

191

1063

1.43

5.26

1.2

246.77

362.12

u/l

1.26

177

977

Other diseases of lip and oral mucosa

162

1105

1.47

5.25

1.3

309.96

340.11

u/l

0.15

143

1021

Coagulation defects, purpura and other haemorrhagic conditions

410

1.79

5.24

1.4

1.3

237.33

329.40

u/l

0.95

377

IBD patients in KELA-register

529

1.69

5.24

1.4

1.3

319.00

370.54

u/l

0.23

482

Caries of enamel

217

1957

0.72

5.16

1.2

1.3

354.88

317.50

u/l

0.11

189

1839

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

593

1.64

5.14

1.4

1.3

213.90

286.37

u/l

0.85

551

Pacemaker

129

782

1.54

5.13

1.3

1.2

285.39

351.22

u/l

0.30

120

720

Injury of muscle and tendon at shoulder and upper arm level

139

924

1.51

5.12

1.2

1.3

309.62

383.15

u/l

0.35

130

851

Algoneurodystrophy

3.20

5.05

1.6

1.2

217.42

439.20

u/l

0.63

Social phobias

153

2.30

5.01

1.3

1.2

316.07

308.03

u/l

0.03

142

Hypothyroidism, strict autoimmune

269

1313

1.35

4.97

1.2

296.42

312.01

u/l

0.10

244

1232

Myocardial infarction, strict

154

738

1.48

4.93

1.2

303.45

409.91

u/l

0.54

148

684

Mouth breathing

150

1020

1.47

4.92

1.2

1.3

452.91

351.03

u/l

0.20

143

932

Benign neoplasm: Ascending colon

296

1.90

4.90

1.1

1.2

369.33

337.61

u/l

0.08

270

Other skin changes

419

1.75

4.90

1.8

1.2

186.66

283.69

u/l

1.25

383

Other and unspecified urticaria

427

1.74

4.87

1.3

263.18

296.63

u/l

0.14

390

Symptoms and signs involving the nervous and musculoskeletal systems

217

1584

1.37

4.82

1.1

1.3

244.61

323.34

u/l

0.95

199

1469

Contact with and exposure to communicable diseases

729

0.48

4.79

1.1

1.3

460.24

309.44

u/l

0.31

680

Disorders of other endocrine glands

159

1084

1.45

4.78

1.5

1.2

232.46

324.34

u/l

1.31

144

995

Temporomandibular joint disorders, including avohilmo

164

1107

1.44

4.76

1.4

1.2

305.30

263.16

u/l

0.25

151

1031

Injuries to the neck

544

1.64

4.75

1.2

193.86

319.40

u/l

2.62

497

Benign neoplasm: Rectum, anus and anal canal

438

1.72

4.75

1.2

240.91

292.36

u/l

0.41

400

Other disorders of eyelid

161

1055

1.44

4.74

1.2

201.28

308.79

u/l

1.27

149

977

Reimbursement for rheumatic diseases

209

1513

1.37

4.72

1.3

289.56

332.66

u/l

0.30

194

1403

COPD, hospital admission 2, with asthma infections

116

648

1.54

4.71

1.2

177.19

385.64

u/l

2.51

107

601

Other maternal disorders predominantly related to pregnancy

193

858

1.41

4.71

1.2

1.3

249.01

246.35

u/l

0.01

184

803

Endometriosis of pelvic peritoneum

272

1.88

4.68

1.3

1.2

514.92

194.39

u/l

0.73

254

Other viral diseases, including avohilmo

135

902

1.48

4.66

1.3

352.28

302.09

u/l

0.22

127

827

COPD, hospital admissions

160

936

1.44

4.65

1.4

1.2

205.77

387.95

u/l

2.72

148

867

Polyp of the female genital tract

345

1.63

4.65

1.2

321.62

248.31

u/l

0.30

321

Disorders of the thyroid gland

344

1736

1.29

4.63

1.4

1.2

380.85

303.02

u/l

0.41

318

1620

Drug-induced cataract

3.53

4.63

1.3

1.2

224.87

567.55

u/l

0.72

Disorders of lens

244

1121

1.35

4.62

1.3

1.2

276.81

382.67

u/l

0.99

224

1049

Diseases of arteries, arterioles and capillaries

236

1282

1.35

4.60

1.2

267.36

346.44

u/l

0.73

209

1194

296

1.86

4.58

1.2

1.3

246.45

313.31

u/l

0.59

278

Diseases of pulp and periapical tissues and dental caries

218

811

1.38

4.55

1.3

1.2

329.58

364.67

u/l

0.16

195

760

Inflammatory bowel disease, strict (require KELA)

551

1.62

4.53

1.4

1.3

319.00

368.43

u/l

0.22

501

Chronic sinusitis

151

1047

1.44

4.52

1.1

1.3

210.95

321.95

u/l

1.44

137

978

5-aminosalicylic acid

476

1.66

4.48

1.5

1.2

324.97

361.89

u/l

0.13

431

Disorders of vitreous body

186

1276

1.39

4.46

1.2

215.43

362.66

u/l

2.37

167

1188

Colectomy operation

350

1.78

4.44

1.2

382.98

313.49

u/l

0.24

317

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

372

1.75

4.44

1.2

1.3

185.02

202.81

u/l

0.29

342

Disorders of sclera, cornea, iris and ciliary body

201

1473

1.37

4.42

1.3

202.68

335.21

u/l

3.04

187

1363

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

143

2.25

4.40

1.1

1.3

320.59

284.87

u/l

0.10

132

Stomatitis and related lesions

448

1.68

4.40

1.2

184.38

300.88

u/l

1.97

414

Persons with potential health hazards related to communicable diseases

911

0.55

4.40

1.1

1.3

392.27

307.87

u/l

0.23

843

Endovascular or surgical operations to intracerebral aneurysms

112

2.43

4.39

2.3

1.3

135.44

362.77

u/l

1.62

103

Periapical abscess

173

1241

1.40

4.34

1.3

246.93

353.01

u/l

1.48

156

1148

Primary coxarthrosis, bilateral

108

709

1.53

4.30

1.2

165.13

382.19

u/l

2.92

101

648

Hallux valgus (acquired)

112

526

1.53

4.22

1.2

200.30

306.89

u/l

1.93

103

490

Preterm labour and delivery

546

1.60

4.22

1.2

335.61

224.07

u/l

0.45

507

Disorders of vitreous body and globe

188

1299

1.37

4.19

1.2

217.20

359.28

u/l

2.30

169

1211

Other disorders of eye and adnexa

298

1.82

4.19

1.6

1.3

179.43

295.56

u/l

1.60

275

Other abnormal uterine and vaginal bleeding

322

1.68

4.18

1.2

326.44

255.02

u/l

0.22

297

Valvular heart disease excluding rheumatic fever

159

802

1.42

4.16

1.3

1.2

243.30

397.45

u/l

1.68

148

743

Exclusions for E4_PCOS_CONSORTIUM

253

1198

1.32

4.14

1.4

1.2

275.72

287.75

u/l

0.09

233

1122

Disorders of lipoprotein metabolism and other lipidaemias

292

1373

1.29

4.13

1.2

330.33

339.40

u/l

0.03

264

1291

Non-rheumatic valve diseases

158

797

1.42

4.12

1.3

1.2

244.03

395.07

u/l

1.62

147

739

Persons encountering health services for specific procedures and health care

389

1839

1.25

4.11

1.2

1.3

397.48

284.89

u/l

0.57

357

1727

Cardiomyopathy, other and unspecified

122

2.31

4.10

1.3

1.2

239.93

461.50

u/l

0.89

116

Ankylosing hyperostosis [Forestier]

8.10

4.07

1.3

1.7

255.25

203.60

u/l

—

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

2.88

4.07

2.1

1.3

1547.67

443.07

u/l

0.36

Subjective visual disturbances

623

1.54

4.05

1.3

1.2

162.89

324.25

u/l

4.51

574

Hypothyroidism, other/unspecified

317

1636

1.27

4.05

1.3

1.2

282.36

303.58

u/l

0.17

289

1528

Other viral diseases

104

685

1.52

4.03

1.3

378.15

330.11

u/l

0.15

622

Benign neoplasm: Rectum

385

1.69

3.98

1.2

256.78

309.72

u/l

0.36

350

Coxarthrosis [arthrosis of hip](FG)

191

965

1.36

3.97

1.2

249.41

397.47

u/l

1.44

176

896

Noninflammatory disorders of female genital tract

123

414

1.49

3.95

1.3

1.2

302.73

241.08

u/l

0.29

110

385

Undetermined asthma, excluding more controls

232

1.90

3.94

1.5

1.3

232.59

344.71

u/l

0.58

217

Persons encountering health services in other circumstances, wide

419

1745

1.23

3.92

1.3

1.2

219.44

346.16

u/l

2.83

377

1639

Enthesopathies of lower limb, excluding foot

417

1.66

3.92

1.8

1.2

257.65

410.18

u/l

0.74

381

Other and unspecified epidermal thickening

3.29

3.91

1.1

110.07

578.78

u/l

1.11

Gonarthrosis,primary

324

1543

1.27

3.90

1.3

1.2

219.93

347.74

u/l

1.97

303

1437

Undetermined asthma

233

1.89

3.89

1.5

1.3

232.59

316.00

u/l

0.42

219

Car occupant injured in other and unspecified transport accidents

418

1.66

3.89

1.3

220.05

318.95

u/l

0.82

389

Meniscus derangement

184

894

1.37

3.88

1.3

1.2

269.39

397.71

u/l

1.26

165

834

Disorders of ocular muscles, binocular movement, accommodation and refraction

172

1248

1.37

3.86

1.3

201.43

350.51

u/l

3.09

167

1143

Hypothyreosis and Thyroxine purchase for inclusion criteria

327

1700

1.26

3.84

1.3

1.2

278.49

320.45

u/l

0.38

298

1589

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

227

1578

1.31

3.81

1.2

1.3

354.83

332.26

u/l

0.07

210

1471

Diseases of oral cavity, salivary glands and jaws

180

674

1.38

3.80

1.2

341.72

291.63

u/l

0.25

158

646

Other and unspecified disorders of vitreous body

152

1070

1.39

3.78

1.2

234.55

351.80

u/l

1.37

139

994

Misadventures to patients during surgical and medical care

287

1.78

3.75

1.3

1.2

165.05

330.21

u/l

2.40

264

Congenital malformations, deformations and chromosomal abnormalities

205

1467

1.33

3.74

1.2

1.3

240.90

338.71

u/l

1.48

189

1366

Acetic acid derivatives and related substances

251

1.63

3.73

1.3

1.2

445.46

242.00

u/l

0.75

240

Persons encountering health services for specific procedures, not carried out

188

1.98

3.72

1.2

1.3

1845.03

361.50

u/l

0.78

175

Chronic kidney disease

107

698

1.48

3.68

1.2

189.77

378.93

u/l

1.44

649

Elevated blood glucose level

148

2.10

3.68

1.3

193.13

401.96

u/l

1.51

137

L04AD Calcineurin inhibitors

210

1.91

3.66

1.2

1.3

205.57

374.97

u/l

1.46

197

Puerperal sepsis

261

1.81

3.63

1.3

181.87

241.38

u/l

0.83

237

Chronic diseases of tonsils and adenoids

269

1325

1.28

3.61

1.2

1.3

488.44

317.36

u/l

0.67

252

1242

Colonic or urogenital fistula

627

1.50

3.55

1.3

232.55

343.10

u/l

1.40

572

Persons encountering health services for examination and investigation

227

867

1.31

3.55

1.3

1.2

317.37

368.49

u/l

0.28

209

817

Heart failure and bmi 25plus

118

543

1.45

3.53

1.2

221.09

335.59

u/l

0.68

112

498

Inflammatory disorders of breast

112

2.24

3.48

1.3

190.36

301.48

u/l

0.55

102

Bicipital tendinitis

2.48

3.46

1.2

203.00

456.97

u/l

1.06

Endometriosis

102

397

1.50

3.46

1.2

368.42

244.17

u/l

0.44

370

Other and unspecified mononeuropathies, also in other diseases

3.00

3.42

1.3

1.2

268.86

549.60

u/l

0.61

Triptan medication for migraine, min. 3 purchases

195

1110

1.31

3.29

1.4

1.2

276.16

273.96

u/l

0.01

182

1041

Conjunctivitis (acute, non atopic), including avohilmo

362

1788

1.22

3.26

1.3

1.2

235.68

342.69

u/l

1.89

334

1667

Other contact dermatitis

142

2.05

3.26

1.4

1.2

211.90

304.64

u/l

0.54

131

Unspecified haematuria

146

872

1.36

3.22

1.5

1.2

252.47

400.33

u/l

1.53

136

809

Familial hypercholesterolemia, with ischemic heart disease

136

2.07

3.21

1.3

1.1

177.78

375.34

u/l

1.31

126

Ehlers-Danlos syndrome, including avohilmo

4.23

3.21

1.2

220.90

893.32

u/l

—

Nonalcoholic fatty liver disease

206

1.85

3.20

1.1

1.3

385.14

352.98

u/l

0.06

193

Ganglion

394

1.60

3.20

1.2

423.79

328.12

u/l

0.34

365

Exclusions for E4_PCOS_BROAD

363

1.63

3.19

1.8

1.3

196.54

331.05

u/l

1.71

334

Focal epilepsy, mode (most common among epilepsy diagnosis)

403

1.59

3.16

1.1

1.2

334.96

332.75

u/l

0.01

370

Missing teeth due to accident, extraction or parodontitis

221

1544

1.28

3.15

1.2

308.21

339.36

u/l

0.19

192

1445

Mental and behavioural disorders due to cannabinoids

2.97

3.14

1.4

1.2

215.15

635.56

u/l

0.84

Pneumonitis due to solids and liquids

145

2.01

3.09

1.4

1.2

216.09

384.74

u/l

1.07

136

Other diseases of spinal cord

2.82

3.09

1.1

1.4

189.00

495.00

u/l

0.78

Mild mental retardation

3.20

3.06

1.1

183.15

513.69

u/l

0.65

Somnolence, stupor and coma

2.51

3.04

1.2

125.27

537.32

u/l

1.55

Nontoxic goitre/thyroid nodule

658

1.45

3.03

1.9

1.2

310.01

233.16

u/l

0.32

604

Focal epilepsy, strict definition

425

1.56

2.98

1.1

1.2

331.37

328.56

u/l

0.01

390

Other disorders of skin and subcutaneous tissue

255

1724

1.25

2.98

1.4

1.2

207.84

333.67

u/l

2.74

223

1616

Endometriosis ASRM stages 1,2

363

1.60

2.96

1.3

496.65

221.08

u/l

0.63

334

Persons encountering health services in other circumstances

143

1055

1.34

2.95

1.3

1.2

250.96

352.44

u/l

0.83

128

983

Postmenopausal bleeding

284

1.51

2.94

1.1

1.2

306.14

257.66

u/l

0.14

267

Fracture of shoulder and upper arm

121

880

1.38

2.91

1.7

1.2

321.07

338.19

u/l

0.08

116

808

Disorders of breast

164

1098

1.32

2.91

1.2

177.91

256.99

u/l

1.61

153

1028

Uterine polyps

334

1.49

2.90

1.2

216.69

251.62

u/l

0.33

310

Dermatophytosis, including avohilmo

228

1777

1.26

2.89

1.2

520.18

312.56

u/l

0.57

209

1662

Neuromuscular dysfunction of bladder

150

1.94

2.84

1.2

121.83

384.70

u/l

2.53

141

Sequelae of injuries, of poisoning and of other consequences of external causes

560

1.47

2.84

1.2

303.41

346.95

u/l

0.18

506

Other embolism and thrombosis

252

1.71

2.84

1.1

1.2

175.97

318.53

u/l

1.63

230

Other inflammatory liver diseases

116

2.08

2.82

1.5

1.4

1468.83

349.90

u/l

0.44

107

Glomerular diseases

376

1.57

2.82

1.3

1.2

147.43

363.58

u/l

4.04

346

Viral warts, including avohilmo

504

1.49

2.81

1.2

1.3

216.84

300.85

u/l

1.08

458

Senile cataract

208

991

1.28

2.81

1.2

288.36

387.79

u/l

0.75

188

927

Acute appendicitis, with complications

408

1.55

2.80

1.2

1.3

244.01

414.74

u/l

1.44

376

Dialysis, with operation codes

253

1.71

2.80

1.2

193.89

372.83

u/l

1.44

234

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

361

1.58

2.79

1.5

1.3

227.41

379.01

u/l

1.30

334

Focal brain injury

2.23

2.79

1.2

1.3

266.75

335.84

u/l

0.32

Conjunctivitis

262

1707

1.24

2.79

1.6

1.2

217.45

338.55

u/l

2.69

248

1587

Malignant neoplasm, including Hilmo

301

1433

1.22

2.79

1.2

1.3

303.77

335.14

u/l

0.22

282

1329

Coronary artery bypass grafting

365

1.51

2.78

1.2

1.1

159.98

522.97

u/l

2.52

342

Disorders of conjunctiva

291

1845

1.22

2.78

1.5

1.2

214.19

333.28

u/l

2.97

277

1713

COPD, hospital admissions 3, with asthma pneumonia sepsis

494

1.46

2.78

1.3

1.2

172.49

402.26

u/l

1.98

455

Deviated nasal septum

110

795

1.38

2.78

1.2

1.3

467.35

375.62

u/l

0.14

740

Other noninflammatory disorders of uterus, except cervix

285

1.55

2.76

1.3

1.2

225.95

258.37

u/l

0.15

265

Viral pneumonia

247

1.71

2.75

1.1

1.3

205.41

368.03

u/l

1.10

228

Residual foreign body in soft tissue

2.21

2.73

1.5

1.2

328.88

520.43

u/l

0.50

Benign thyroid growths and nodules

108

725

1.39

2.73

1.8

1.2

330.20

249.28

u/l

0.37

103

667

Other viral diseases, not elsewhere classified, including avohilmo

635

1.43

2.73

1.3

449.52

331.92

u/l

0.39

583

Other diseases of the respiratory system

419

1.53

2.72

1.2

272.38

289.31

u/l

0.07

379

Other respiratory disorders and diseases

419

1.53

2.72

1.2

272.38

289.31

u/l

0.07

379

Medical abortion

205

870

1.28

2.72

1.3

1.2

200.33

264.53

u/l

0.96

187

818

Other diseases of pleura

150

990

1.32

2.72

1.1

1.2

254.34

372.47

u/l

1.00

136

915

Other disorders of breast and lactation associated with childbirth

3.78

2.68

1.2

1.0

189.33

329.05

u/l

—

Focal epilepsy

469

1.50

2.68

1.1

1.2

325.18

328.08

u/l

0.01

426

Hypothyroidism, strict autoimmune, 3 medication purchases required

288

1588

1.22

2.65

1.2

295.82

320.19

u/l

0.17

262

1484

Malignant neoplasm, wide definition

300

1436

1.22

2.64

1.2

1.3

305.10

334.84

u/l

0.21

281

1332

Motorcycle rider injured in other and unspecified transport accidents

2.16

2.61

1.5

1.4

213.45

533.91

u/l

1.30

Diabetic retinopathy, strict definition

447

0.55

2.56

1.1

1.3

91.09

287.90

u/l

2.72

413

Fracture of lower leg, including ankle

184

1425

1.27

2.56

1.3

1.2

300.62

353.01

u/l

0.32

170

1317

Ingrowing nail

2.23

2.54

1.5

1.3

100.78

504.69

u/l

1.84

Liquid cancers

653

1.39

2.53

1.3

1.2

210.08

399.16

u/l

1.88

601

Dental operations

197

798

1.27

2.52

1.2

309.19

368.36

u/l

0.30

172

765

Female genital prolapse

323

1.45

2.51

1.7

1.2

297.97

253.33

u/l

0.16

300

Primary_lymphoid and hematopoietic malignant neoplasms

542

1.44

2.51

1.3

1.2

203.62

432.44

u/l

1.81

494

Papulosquamous disorders

137

1044

1.31

2.51

1.2

292.31

360.72

u/l

0.34

123

965

Etanercept

115

2.01

2.50

1.1

1.3

190.39

338.82

u/l

0.83

104

Suppurative and unspecified otitis media

112

733

1.35

2.48

1.6

1.3

239.60

322.40

u/l

0.87

104

677

Postmenopausal atrophic vaginitis

286

1.47

2.48

1.2

155.19

255.13

u/l

1.30

267

Gingivitis and periodontal diseases

344

1488

1.19

2.47

1.2

1.3

336.82

303.96

u/l

0.24

309

1402

Factors influencing health status and contact with health services

338

1.41

2.45

1.4

1.2

432.78

411.70

u/l

0.05

320

Propionic acid derivatives

272

1.46

2.45

1.2

441.86

243.62

u/l

0.66

258

Ectopic pregnancy

358

1.54

2.44

1.2

1.3

198.42

243.33

u/l

0.46

332

Type 1 diabetes

528

1.44

2.44

1.6

1.2

164.42

445.64

u/l

2.76

484

Scabies

2.25

2.44

1.4

1.3

121.47

412.94

u/l

1.41

Supplementary factors related to causes of morbidity and mortality classified elsewhere

105

773

1.36

2.43

1.3

1.2

522.47

372.10

u/l

0.24

712

Haemorrhage in early pregnancy

578

1.41

2.43

1.3

269.48

231.38

u/l

0.32

537

Ulcerative colitis (strict definition, require KELA)

375

1.52

2.41

1.5

1.3

227.41

370.77

u/l

1.25

346

Event of undetermined intent

118

1.96

2.35

1.3

299.35

411.75

u/l

0.38

108

Benign mammary dysplasia

298

1.58

2.35

1.2

163.15

280.62

u/l

1.34

270

Non-ischemic cardiomyopathy

520

1.39

2.34

1.4

1.2

279.70

438.67

u/l

0.60

478

Acute suppurative otitis media

528

1.41

2.32

1.4

1.3

332.07

323.71

u/l

0.03

491

Calcific aortic valvular stenosis, including rheumatic fever

626

1.38

2.32

1.2

194.39

386.36

u/l

1.85

579

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

411

1.49

2.32

1.4

1.3

232.05

378.79

u/l

1.41

379

Vestibular neuronitis

169

1.78

2.32

1.5

1.3

226.33

332.60

u/l

0.73

154

Abnormalities of forces of labour

184

1.74

2.31

1.3

164.94

225.97

u/l

0.88

170

Familial hypercholesterolemia

316

1.55

2.29

1.3

1.2

219.07

425.19

u/l

1.14

297

Complications of labour and delivery

188

831

1.26

2.28

1.2

269.60

248.15

u/l

0.13

174

778

Other fall from one level to another

528

1.42

2.28

1.5

1.3

292.27

352.56

u/l

0.25

486

Other diseases of hard tissues of teeth

166

673

1.28

2.28

1.3

1.2

277.49

291.50

u/l

0.07

152

645

Malignant neoplasm

288

1407

1.20

2.25

1.2

1.3

293.75

335.75

u/l

0.33

271

1305

Nonsuppurative otitis media, including avohilmo

624

1.36

2.25

1.4

1.2

253.61

300.09

u/l

0.37

577

Nephropathy related operations

247

1.62

2.24

1.2

1.3

190.76

377.01

u/l

1.45

228

Other enthesopathy of foot (+metatarsalgia)

171

1.76

2.24

1.2

164.56

357.86

u/l

1.73

159

Injuries to the hip and thigh

160

1134

1.27

2.22

1.3

1.2

355.36

331.52

u/l

0.09

149

1047

Diseases of the myoneural junction and muscle

240

1.63

2.21

1.2

490.76

331.26

u/l

0.26

224

Female infertility

324

1.43

2.21

1.2

1.1

206.97

202.37

u/l

0.06

304

Iridocyclitis

507

1.42

2.20

1.4

1.3

202.68

316.32

u/l

1.98

464

Calcific aortic valvular stenosis, diagnosis (helper)

625

1.37

2.20

1.2

195.59

386.36

u/l

1.83

579

Operations 2 for CAVS

625

1.37

2.20

1.2

195.59

386.36

u/l

1.83

579

Rheumatoid arthritis

620

1.36

2.18

1.3

1.2

261.09

443.27

u/l

1.24

577

Malignant neoplasm

288

1412

1.20

2.18

1.2

1.3

294.62

336.33

u/l

0.33

271

1310

Psoriasis vulgaris

418

1.46

2.16

1.2

314.82

398.82

u/l

0.30

384

Calcific aortic valvular stenosis, operated

628

1.37

2.15

1.2

195.59

385.43

u/l

1.82

582

Calcific aortic valvular stenosis

628

1.37

2.15

1.2

195.59

385.43

u/l

1.82

582

Exposure to other and unspecified inanimate mechanical forces

144

1.81

2.14

1.1

1.3

255.50

385.42

u/l

0.71

132

Cerebrovascular diseases

244

1402

1.21

2.13

1.4

1.2

189.62

349.97

u/l

4.12

227

1297

Other and unspecified myopathies

167

1.74

2.11

1.1

1.2

616.91

398.45

u/l

0.24

154

Pneumonia derived septicemia

2.46

2.10

1.6

1.2

135.75

497.18

u/l

0.96

Keratitis

117

899

1.30

2.08

1.3

172.33

382.03

u/l

3.52

110

821

Lichen planus

260

1.58

2.08

1.1

1.3

376.06

268.14

u/l

0.19

236

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

5.10

2.08

1.0

145.80

356.90

u/l

—

Sulfasalazine

657

1.36

2.08

1.2

294.58

336.24

u/l

0.23

598

Wet age-related macular degeneration

335

1.50

2.08

1.2

398.62

272.65

u/l

0.28

313

Disorders of purine and pyrimidine metabolism

5.09

2.08

1.0

145.80

356.90

u/l

—

Other degenerative diseases of the nervous system

384

1.41

2.06

1.2

185.09

394.93

u/l

1.71

364

Other diseases of blood and blood-forming organs, wide

498

1.41

2.05

1.7

1.2

387.60

311.58

u/l

0.28

456

Golimumab

2.19

2.05

1.3

1.2

159.80

427.34

u/l

0.98

Motorcycle rider injured in noncollision transport accidents

2.41

2.03

1.2

210.25

660.86

u/l

1.06

Injury of intra-abdominal organs

2.65

2.00

1.3

441.60

624.21

u/l

—

Complications of genitourinary prosthetic devices, implants and grafts

2.65

2.00

1.2

1.1

331.80

320.88

u/l

—

Injury of other and unspecified intrathoracic organs

104

1.93

2.00

1.4

1.2

270.57

579.21

u/l

1.28

Varicose veins

200

1238

1.22

2.00

1.3

1.2

251.02

332.57

u/l

0.84

187

1151

Anti-inflammatory and antirheumatic products, non-steroids

272

1.41

1.99

1.2

465.86

243.62

u/l

0.75

258

Other follicular disorders

126

1.83

1.98

1.2

1.3

232.96

403.45

u/l

0.90

116

Metatarsalgia

163

1.72

1.98

1.2

166.57

367.10

u/l

1.71

152

Rubella [German measles]

2.09

1.97

1.0

1.2

1356.69

538.76

u/l

0.31

Rubella [German measles], including avohilmo

2.09

1.97

1.0

1.2

1356.69

538.76

u/l

0.31

Fracture at wrist and hand level

112

861

1.30

1.96

1.4

1.2

563.08

347.87

u/l

0.39

104

784

Hordeolum and other deep inflammation of eyelid

112

1.88

1.96

1.1

1.3

224.90

413.59

u/l

0.83

103

Ulcerative colitis (strict definition, all Crohn cases excluded)

313

1.51

1.94

1.6

1.3

205.00

329.68

u/l

1.42

293

Assault by unspecified means

2.58

1.94

1.2

443.70

491.91

u/l

—

Aortic aneurysm

494

1.39

1.93

1.2

212.43

435.74

u/l

1.70

463

Solid cancers

280

1389

1.18

1.92

1.2

1.3

291.33

336.71

u/l

0.36

266

1288

Anankastic personality disorder

2.12

1.92

1.1

1.3

359.20

411.18

u/l

0.10

Pediculosis, acariasis and other infestations

106

1.89

1.90

1.4

1.3

106.30

436.39

u/l

2.22

Solid cancers, including Hilmo

285

1412

1.18

1.86

1.2

1.3

311.78

335.76

u/l

0.16

269

1309

Psoriasis

697

1.32

1.85

1.2

271.66

378.31

u/l

0.60

641

Atrophic disorders of skin

358

1.46

1.85

1.1

1.3

138.23

310.83

u/l

3.22

327

Contact with machinery

221

1.59

1.84

1.2

350.40

476.40

u/l

0.42

203

Nonsuppurative otitis media

405

1.39

1.80

1.5

1.2

289.05

303.12

u/l

0.06

372

Diseases of male genital organs

159

645

1.24

1.79

1.2

1.3

495.61

392.33

u/l

0.21

147

599

423

1.39

1.76

1.3

1.2

170.28

261.35

u/l

1.15

390

Herpesviral [herpes simplex] infections

232

1.56

1.75

1.7

1.2

211.90

296.41

u/l

0.82

213

Other epidermal thickening

1.94

1.75

1.1

1.3

115.94

480.06

u/l

1.83

Car occupant injured in noncollision transport accident

2.14

1.71

1.3

306.54

604.38

u/l

0.60

Certain disorders involving the immune mechanism

423

1.40

1.71

1.3

1.2

245.76

322.72

u/l

0.54

385

Major anomalies of jaw size

2.31

1.71

1.2

1.1

204.36

529.86

u/l

0.75

Autoimmune hepatitis, wide definition

1.96

1.69

1.7

1.4

2122.25

387.84

u/l

0.46

Other and/or unspecified nontoxic goitre

164

1.65

1.67

2.6

1.2

155.22

283.40

u/l

1.09

145

Mental retardation

2.05

1.66

1.1

1.4

179.43

402.62

u/l

0.76

Other symptoms and signs involving the nervous and musculoskeletal systems

134

1082

1.24

1.66

1.1

1.3

266.42

358.28

u/l

0.69

119

995

Disorders of choroid and retina

268

1610

1.17

1.65

1.2

242.71

345.59

u/l

1.10

242

1498

Atherosclerosis, excluding cerebral and coronary sclerosis

125

785

1.25

1.64

1.2

201.59

387.25

u/l

2.20

109

727

Covid-19 confirmed case

122

975

1.25

1.64

1.7

1.2

195.49

356.07

u/l

2.18

114

893

Maternal care for other known or suspected fetal problems

328

1.36

1.64

1.2

212.86

226.46

u/l

0.10

307

Fibroblastic disorders

479

1.36

1.61

1.4

1.2

777.39

364.16

u/l

0.43

444

Postprocedural musculoskeletal disorders, not elsewhere classified

143

1.68

1.61

1.2

1.3

175.33

375.72

u/l

1.46

133

Cleft lip, lip and palate or palate

2.71

1.58

1.0

1.2

580.43

691.29

u/l

—

D07AA Corticosteroids, weak (group I)

320

1.44

1.57

1.2

1.3

180.03

308.96

u/l

1.56

296

Mumps, including avohilmo

2.21

1.57

1.0

1.2

169.55

540.57

u/l

0.99

Pneumococcal septicemia

2.21

1.57

1.6

1.2

136.64

506.48

u/l

0.99

Lichen planus, including avohilmo

448

1.36

1.56

1.1

1.3

309.78

316.04

u/l

0.01

416

Invasive ventilation

137

1.68

1.55

1.4

1.3

221.48

408.98

u/l

1.04

125

570

1.30

1.54

1.3

1.2

292.04

283.38

u/l

0.03

527

Disturbances of smell and taste

1.98

1.54

1.2

1.3

182.57

438.35

u/l

1.03

L04AA Selective immunosuppressants

527

1.33

1.53

1.2

1.3

182.29

347.14

u/l

2.42

481

Persons encountering health services for other counselling and medical advice, not elsewhere classified

372

1744

1.13

1.51

1.4

1.2

219.64

346.14

u/l

2.76

339

1638

COPD, hospital admissions 1, only main diagnosis

101

686

1.27

1.51

1.4

1.2

204.98

370.15

u/l

1.65

632

Mental retardation, wide definition

1.96

1.50

1.1

1.4

179.43

400.21

u/l

0.79

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

748

1.27

1.50

1.4

1.3

247.87

360.74

u/l

0.96

689

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

1.91

1.49

1.0

1.3

234.07

408.42

u/l

0.64

Type 1 diabetes, wide definition, subgroup 1

367

1.39

1.47

1.2

133.91

253.62

u/l

3.87

341

Sequelae of injuries of head

1.81

1.47

1.4

1.3

162.65

389.45

u/l

1.19

Lichen sclerosus et atrophicus

251

1.48

1.47

1.2

131.66

275.43

u/l

1.98

228

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

276

1.45

1.46

1.4

1.3

449.86

308.45

u/l

0.23

256

Polyarthritis, unspecified

2.04

1.43

1.7

1.3

707.42

467.46

u/l

0.18

Dislocation, sprain and strain of joint and ligaments of hip

2.04

1.43

1.3

1.2

192.58

293.37

u/l

0.49

Visual field defects

156

1.61

1.43

1.2

1.3

190.36

377.66

u/l

1.04

142

Peripheral arterial reconstruction

336

1.40

1.43

1.1

1.2

138.30

374.32

u/l

2.11

310

Anomalies of dental arch relationship, including avohilmo

404

1.34

1.41

1.5

1.3

260.58

321.06

u/l

0.32

375

Seropositive rheumatoid arthritis

523

1.31

1.40

1.4

1.2

273.24

412.63

u/l

0.66

475

Unspecified event, undetermined intent

2.26

1.40

1.4

1.2

437.22

591.44

u/l

—

Mumps

2.19

1.40

1.0

1.3

184.90

552.73

u/l

—

Foreign body or object entering through skin

111

1.72

1.39

1.1

1.3

1117.89

418.18

u/l

0.31

101

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

2.08

1.38

1.9

1.2

723.91

406.50

u/l

0.22

Chronic periodontitis, including avohilmo

331

1866

1.13

1.38

1.1

1.3

369.44

309.27

u/l

0.52

299

1749

Diagnoses used for exclusion with ILD

580

1.29

1.38

1.3

1.2

336.01

354.90

u/l

0.05

529

Convergent concomitant strabismus

104

1.74

1.37

1.3

198.50

375.72

u/l

0.89

Cellulitis

529

1.31

1.36

1.4

1.2

216.68

363.99

u/l

1.07

485

Diffuse large B-cell lymphoma, including Hilmo

1.84

1.35

1.1

1.2

141.47

401.85

u/l

1.29

Diffuse large B-cell lymphoma

1.84

1.35

1.1

1.2

141.47

401.85

u/l

1.29

Diffuse large B-cell lymphoma, helper endpoint

1.84

1.35

1.1

1.2

141.47

401.85

u/l

1.29

Any event in cancer register

299

1536

1.14

1.33

1.2

1.3

320.44

322.37

u/l

0.01

280

1429

Benign neoplasm: Skin of eyelid, including canthus

324

1.39

1.33

1.4

1.2

199.32

293.05

u/l

1.09

296

Glucosamine medication

138

915

1.20

1.33

1.2

371.92

333.10

u/l

0.07

131

839

Injury of nerves at wrist and hand level

2.04

1.33

1.2

1.3

133.00

313.61

u/l

1.51

Other disorders of conjunctiva

291

1.41

1.32

1.2

174.37

306.44

u/l

1.67

264

Thyroiditis, ILD-related definition

225

1.47

1.30

1.2

1.3

319.21

286.97

u/l

0.08

204

Other encephalitis

2.10

1.30

1.2

1.1

416.22

469.32

u/l

—

Prolonged pregnancy

273

0.62

1.30

1.1

1.3

187.05

230.11

u/l

0.51

254

Periodontitis

330

1868

1.13

1.29

1.1

1.3

370.20

309.31

u/l

0.53

298

1751

Other puerperal infections

145

1.59

1.28

1.2

1.3

153.30

263.47

u/l

1.50

131

Injuries to the elbow and forearm

233

1740

1.15

1.28

1.3

1.2

224.17

333.41

u/l

1.71

221

1611

Lichen ruber planus, wide definition including periferal and oral lichen planus

535

1.29

1.27

1.1

1.2

284.85

309.00

u/l

0.07

495

Schizotypal disorder

2.06

1.27

1.1

1.3

183.22

649.89

u/l

—

Contact with sharp object, undetermined intent

2.05

1.27

1.0

1.3

171.22

530.90

u/l

—

Alopecia areata

2.05

1.27

1.3

1.2

337.44

530.21

u/l

—

Benign neoplasm: Skin of other and unspecified parts of face

202

1.49

1.27

1.0

1.2

746.09

311.53

u/l

0.53

187

Non-follicular lymphoma

178

1.52

1.26

1.2

158.04

352.03

u/l

1.89

165

Benign lipomatous neoplasm of other sites/unspecified

154

1.56

1.25

1.3

464.71

322.48

u/l

0.24

144

Other specific arthropathies, wide

2.23

1.24

1.0

1.2

789.63

619.65

u/l

—

Leisure time condition

406

1.33

1.24

1.3

1.2

292.37

307.14

u/l

0.06

375

Other and unspecified follicular disorders

1.86

1.24

1.2

1.3

230.38

431.37

u/l

0.66

Other inflammation of eyelid

304

1.38

1.22

1.3

1.2

160.46

299.00

u/l

1.75

279

Benign lipomatous neoplasm

717

1.24

1.21

1.3

1.2

399.48

307.91

u/l

0.29

656

Chronic periodontitis, complicated

183

1536

1.16

1.21

1.1

1.3

349.62

342.50

u/l

0.04

166

1428

Other respiratory diseases principally affecting the interstitium

365

1.34

1.20

1.1

1.2

230.88

290.08

u/l

0.55

330

Cysts of oral region, not elsewhere classified

101

1.69

1.19

1.3

350.94

445.67

u/l

0.22

Other inflammation of eyelid, including avohilmo

138

1164

1.19

1.2

1.3

188.67

330.82

u/l

3.02

124

1079

Procreative management

693

0.78

1.18

1.8

1.3

218.92

322.85

u/l

1.34

649

Stroke, including SAH

193

1197

1.16

1.18

1.3

1.2

179.86

355.84

u/l

3.91

180

1106

Other infectious diseases, including avohilmo

165

1.52

1.17

1.2

240.20

371.09

u/l

0.67

151

Benign neoplasm of other and unspecified sites

2.01

1.16

1.1

1.2

121.30

473.69

u/l

—

Rheumatoid arthritis, including avohilmo

111

921

1.21

1.15

1.3

1.2

276.77

344.45

u/l

0.45

103

850

Stroke, excluding SAH

182

1134

1.16

1.14

1.3

1.2

185.55

362.59

u/l

3.51

170

1046

Other disorders of binocular movement

2.01

1.12

1.3

1.2

283.50

483.46

u/l

—

Diseases of middle ear and mastoid

173

1221

1.16

1.10

1.5

1.3

252.87

342.79

u/l

1.04

160

1125

Caries in Clefts patients

2.40

1.09

1.0

1.2

629.00

846.63

u/l

—

Hyperfunction of pituitary gland

1.73

1.09

1.1

1.2

144.64

377.18

u/l

0.95

Other infectious diseases

136

1.55

1.08

1.2

221.86

342.39

u/l

0.53

122

Third [oculomotor] nerve palsy

2.13

1.05

1.7

1.1

211.00

687.54

u/l

—

Secondary right heart disease

1.80

1.04

1.1

1.2

120.42

388.36

u/l

1.00

Allergic contact dermatitis

271

1.37

1.04

1.1

1.3

158.55

301.68

u/l

1.87

249

Encephalitis

1.96

1.03

1.2

416.22

462.68

u/l

—

Atopic dermatitis, strict definition with reimbursement

660

1.22

1.03

1.2

1.3

176.46

305.68

u/l

2.41

614

Other and unspecified corneal deformities and disorders

1.84

1.03

1.5

1.2

109.00

461.11

u/l

1.24

Tonsillectomy and adenotomy

164

988

1.16

1.02

1.2

1.3

300.30

313.84

u/l

0.09

155

918

Presence of other functional implants

181

1082

1.15

1.00

1.3

1.2

240.05

384.47

u/l

1.67

169

1008

Coxarthrosis, primary

185

1346

1.14

1.00

1.2

232.38

353.92

u/l

1.38

172

1250

Redundant prepuce, phimosis and paraphimosis

476

1.26

0.99

1.3

238.17

428.19

u/l

2.29

439

Lesion of plantar nerve

107

1.59

0.99

1.4

1.2

186.12

327.69

u/l

0.71

Other pulmonary heart/vessel disease

1.72

0.99

1.1

1.2

118.08

368.03

u/l

1.11

Type of accident

719

1.21

0.98

1.4

1.2

573.69

332.16

u/l

0.34

662

Artificial joint operation, meniscal resection

296

1705

1.11

0.98

1.3

1.2

214.74

349.34

u/l

3.03

273

1588

Diabetic retinopathy

652

0.83

0.97

1.2

1.3

118.14

261.30

u/l

2.91

609

Supervision of normal pregnancy

296

0.75

0.97

1.2

1.3

207.93

256.95

u/l

0.35

283

Chondromalacia

1.81

0.96

1.0

1.3

221.22

475.16

u/l

—

Intermittent heterotropia

108

1.57

0.95

1.1

1.2

212.06

344.06

u/l

0.62

Maternal care for known or suspected disproportion

1.69

0.95

1.2

137.85

257.51

u/l

1.08

Other articular cartilage disorders

1.90

0.94

1.1

1.2

111.57

617.23

u/l

—

Otitis externa

542

1.24

0.94

1.4

1.3

705.12

358.68

u/l

0.32

493

Gonarthrosis, primary, with knee surgery

177

1210

1.14

0.93

1.4

1.2

195.90

362.82

u/l

2.60

163

1129

Sub-endpoint used in defining T1D endpoints

650

1.21

0.92

1.5

1.2

169.12

336.61

u/l

2.34

593

Dislocation, sprain and strain of joints and ligaments of elbow

118

1.53

0.90

2.3

1.2

219.94

385.76

u/l

0.68

107

Unspecified kidney failure

185

1.41

0.89

1.2

127.55

355.66

u/l

2.54

177

Maternal care related to the fetus and amniotic cavity and possible delivery problems

126

634

1.17

0.89

1.3

1.2

285.33

219.66

u/l

0.35

119

598

Macular hole

105

0.48

0.88

1.0

1.2

206.80

383.88

u/l

—

Peripheral artery disease

125

851

1.16

0.87

1.1

1.2

186.44

394.33

u/l

2.65

106

788

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

2.01

0.87

1.7

1.2

105.83

652.16

u/l

—

Glaucoma suspect

104

886

1.17

0.87

1.1

1.2

188.28

343.87

u/l

2.09

825

Disorders of optic nerve and visual pathways

178

1.41

0.86

1.2

1.3

297.80

370.55

u/l

0.34

163

Retinal detachments and breaks

106

907

1.17

0.85

1.2

244.06

371.86

u/l

0.92

842

Unspecific neurodegenerative disorder

692

0.84

1.2

206.21

352.64

u/l

1.40

636

Other or ill-defined heart diseases

1.59

0.84

1.4

1.3

284.14

484.86

u/l

0.69

Provisional assignment of new diseases of uncertain etiology

163

1428

1.13

0.84

1.5

1.2

199.73

326.76

u/l

2.36

148

1320

Codes for special purposes

163

1428

1.13

0.83

1.5

1.2

199.73

326.76

u/l

2.36

148

1320

Retinal detachment with retinal break

266

1.32

0.82

1.1

1.2

408.43

374.72

u/l

0.06

246

Abnormal findings on examination of urine, without diagnosis

1.61

0.81

1.2

530.46

390.74

u/l

0.25

Labour and delivery complicated by umbilical cord complications

1.61

0.81

1.3

193.77

275.84

u/l

0.50

Fracture of femur

547

1.20

0.81

1.2

309.12

271.91

u/l

0.15

499

Follow-up examination after treatment for conditions other than malignant neoplasms

129

747

1.15

0.80

1.2

255.50

364.76

u/l

0.88

114

702

Maternal care for known or suspected fetal abnormality and damage

279

0.73

0.80

1.2

1.3

219.54

233.68

u/l

0.12

260

Insulin, fast-acting (human)

259

1.31

0.79

1.1

1.3

78.21

380.64

u/l

5.52

238

Congenital malformations of uterus and cervix

1.82

0.79

1.2

1.1

252.50

583.68

u/l

—

Leiomyoma of uterus

184

919

1.12

0.79

1.5

1.2

244.84

259.40

u/l

0.09

170

859

Other and unspecified diseases of blood and blood-forming organs

1.67

0.79

1.0

1.1

407.13

513.67

u/l

—

Later onset COPD

481

1.20

0.78

1.2

195.27

352.87

u/l

1.12

448

Ankylosing spondylitis, strict definition

1.63

0.78

1.6

1.3

261.17

517.40

u/l

0.69

Amiodarone users

199

1.36

0.78

1.3

1.2

193.63

379.83

u/l

1.73

185

conjunctival haemorrhage

140

1.43

0.76

1.3

1.2

183.40

378.98

u/l

1.23

128

Benign neoplasm of thyroid gland

1.70

0.76

1.3

1.2

595.10

449.04

u/l

—

Ischaemic Stroke, excluding all haemorrhages

164

1074

1.12

0.75

1.2

175.06

368.12

u/l

3.86

154

987

Other obstructive and reflux uropathy

1.65

0.75

2.1

1.2

304.45

384.38

u/l

0.17

Myocardial infarction, unclassifiable

401

1.23

0.74

1.2

337.44

374.98

u/l

0.08

369

Other retinal disorders

192

1311

1.11

0.74

1.3

1.2

234.90

339.19

u/l

0.92

174

1218

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

1.85

0.73

1.0

1.1

169.00

598.41

u/l

—

Fall involving bed

1.64

0.73

1.1

1.2

56.00

371.06

u/l

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.01

0.73

1.2

1.1

65.40

659.85

u/l

—

Atopic dermatitis

173

1234

1.12

0.72

1.2

1.3

192.25

328.10

u/l

2.62

155

1156

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

243

1.30

0.72

1.2

200.63

320.97

u/l

0.84

222

In situ neoplasms

1012

0.86

0.72

1.1

1.2

268.67

320.56

u/l

0.23

926

Follow-up examination after treatment for malignant neoplasms

218

0.69

0.71

1.4

1.2

189.73

260.86

u/l

0.67

201

Benign neoplasm: Larynx

1.58

0.71

1.3

137.56

456.79

u/l

—

Acute posthaemorrhagic anaemia

1.58

0.71

1.3

1.2

215.56

481.31

u/l

—

Hyperlipidaemia, other/unspecified

111

871

1.15

0.71

1.1

1.2

246.22

351.19

u/l

0.95

817

Specific development disorders of speech and language

1.49

0.70

1.2

410.33

407.35

u/l

0.01

Benign neoplasm of meninges

212

1.32

0.70

1.2

197.83

262.32

u/l

0.45

191

Loose body in joint

1.71

0.70

1.0

1.3

169.57

613.03

u/l

—

Benign neoplasm: Cerebral meninges

186

1.35

0.70

1.2

1.3

196.20

257.19

u/l

0.37

168

Other intracranial haemorrhages

1.56

0.70

1.0

1.2

195.67

597.72

u/l

—

Problems related to social environment

1.67

0.68

1.0

1.1

117.29

592.43

u/l

—

Squamous cell neoplasms and carcinomas of the skin

187

1.34

0.67

1.2

209.44

335.00

u/l

0.65

169

Myeloid leukaemia

1.63

0.67

1.7

1.1

291.14

462.76

u/l

—

Amputation of thigh

1.63

0.67

1.0

1.1

113.57

462.50

u/l

—

Pregnancy with abortive outcome

187

879

1.11

0.66

1.2

177.88

263.37

u/l

1.56

164

826

Agranulocytosis

214

1.31

0.66

1.3

1.2

407.30

281.65

u/l

0.18

196

Injury of muscle and tendon at forearm level

1.79

0.66

1.2

1.1

248.60

666.30

u/l

—

Tuberculosis of other organs

1.79

0.66

1.0

140.80

620.86

u/l

—

Personality and behavioural disorders due to brain disease, damage and dysfunction

1.79

0.66

1.2

1.1

184.20

585.22

u/l

—

Peripheral artery operations in Hilmo

233

1.29

0.64

1.0

1.2

172.76

333.50

u/l

1.72

218

Other crystal arthropathies

1.73

0.64

1.2

1.3

144.80

706.42

u/l

—

Benign neoplasm: Colon, unspecified

607

1.17

0.63

1.1

1.2

185.47

394.27

u/l

1.78

557

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

155

1.36

0.63

1.1

1.2

133.71

273.47

u/l

1.19

137

Chronic tubulo-interstitial nephritis

1.59

0.61

1.1

1.2

431.50

461.96

u/l

—

Deficiency of other B group vitamins

1.67

0.61

1.2

510.60

629.72

u/l

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

182

1.32

0.61

1.1

1.2

332.42

333.28

u/l

0.00

162

Type 1 diabetes, wide definition

443

1.20

0.60

1.2

1.3

137.43

405.69

u/l

4.39

405

Use of fingolimod

0.00

0.60

0.0

1.2

—

1002.00

—

Optic neuritis

1.50

0.59

1.2

371.25

377.19

u/l

0.01

Traumatic amputation of wrist and hand

1.53

0.59

1.0

1.2

143.82

401.89

u/l

1.53

Other and unspecified injuries of wrist and hand

1.53

0.59

1.0

1.2

207.73

381.50

u/l

0.81

Diseases of external ear

104

921

1.13

0.58

1.3

1.2

496.22

349.06

u/l

0.20

844

Benign neoplasm: Kidney

1.57

0.58

1.1

1.2

111.60

440.49

u/l

—

Failed attempted abortion

0.00

0.58

0.0

1.1

—

905.18

—

Malignant neoplasm of kidney, except renal pelvis

166

1.33

0.58

1.1

1.2

355.91

351.76

u/l

0.01

149

Other acquired deformities of musculoskeletal system and connective tissue

1.48

0.57

1.2

237.00

411.35

u/l

0.65

Benign neoplasm of urinary organs

1.48

0.57

1.1

1.2

137.00

393.80

u/l

1.26

Acne, including avohilmo

354

1.19

0.56

1.2

191.43

327.16

u/l

2.14

328

Left ventricular outflow tract obstruction, narrow definition

1.47

0.54

1.1

1.4

138.50

425.82

u/l

1.46

Respiratory tuberculosis, not confirmed

1.50

0.54

1.1

1.2

187.00

367.17

u/l

—

Other benign neoplasms of skin

104

927

1.12

0.54

1.2

398.80

355.36

u/l

0.12

856

Respiratory tuberculosis, not confirmed, including avohilmo

1.48

0.53

1.1

1.2

187.00

367.17

u/l

—

Biological medicines for asthma

1.54

0.53

1.5

1.2

105.00

589.97

u/l

—

Malignant neoplasm of oesophagus, including Hilmo

1.45

0.53

1.7

1.2

187.89

381.18

u/l

—

Other benign neoplasm of uterus: Other parts/unspecified

1.41

0.51

2.1

1.1

252.56

306.76

u/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

340

1.20

0.51

1.1

1.3

176.65

336.79

u/l

2.55

315

Presence of other devices

555

1.15

0.51

1.2

318.90

386.41

u/l

0.21

510

Lyme disease

837

1.12

0.51

1.3

1.2

304.48

385.97

u/l

0.40

766

Lyme disease, including avohilmo

837

1.12

0.51

1.3

1.2

304.48

385.97

u/l

0.40

766

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

124

1.35

0.51

1.6

1.3

528.53

370.48

u/l

0.17

113

Hypertrophic cardiomyopathy

1.47

0.50

1.2

227.36

411.90

u/l

0.65

Spirochaetal infections, other/unspecified, including avohilmo

847

1.12

0.50

1.3

1.2

305.72

382.87

u/l

0.38

776

Alzheimer disease, including avohilmo

583

0.88

0.50

1.2

167.32

303.45

u/l

1.76

534

Complications of internal orthopaedic prosthetic devices, implants and grafts

491

1.16

0.50

1.2

185.98

333.08

u/l

1.53

450

Degeneration of macula and posterior pole

137

961

1.10

0.50

1.3

1.2

268.63

336.50

u/l

0.35

123

893

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

1.50

0.49

1.4

1.2

224.00

460.29

u/l

—

Burn and corrosion confined to eye and adnexa

1.56

0.49

1.6

1.3

123.57

575.59

u/l

—

Pedestrian injured in collision with pedal cycle

1.56

0.49

3.3

1.1

307.29

550.80

u/l

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

129

794

1.10

0.48

1.2

166.79

336.25

u/l

2.99

118

732

Malignant neoplasm of endocrine gland, including Hilmo

154

1.30

0.48

1.1

1.2

190.10

308.68

u/l

0.81

135

Abnormal findings on diagnostic imaging of central nervous system

1.45

0.48

1.3

265.64

420.59

u/l

0.48

L02BB Anti-androgens

166

0.72

0.47

1.1

309.00

316.07

u/l

0.02

154

Graves disease, strict definition

211

0.76

0.47

1.3

219.63

286.40

u/l

0.45

194

Delivery

531

0.89

0.46

1.3

1.2

194.77

240.67

u/l

0.60

493

Use of anticholinesterases

612

0.88

0.46

1.2

211.70

306.93

u/l

0.89

561

N06DA Anticholinesterases

612

0.88

0.46

1.2

211.70

306.93

u/l

0.89

561

Burns and corrosions confined to eye and internal organs

1.43

0.46

1.6

1.4

123.57

578.64

u/l

—

Clear cell adenocarcinoma of kidney

1.39

0.46

1.1

1.2

475.85

384.47

u/l

0.09

Disorders of orbit

0.61

0.45

2.0

1.4

146.60

394.95

u/l

—

Other spirochaetal diseases, including avohilmo

864

1.11

0.45

1.2

303.81

380.48

u/l

0.38

792

Autoimmune hyperthyroidism

121

0.66

0.45

1.3

1.2

218.00

328.85

u/l

—

110

All dysplastic lesions of the vagina

1.40

0.45

1.3

1.2

176.71

463.25

u/l

—

Contraceptive management

124

790

1.10

0.44

1.2

1.3

286.05

350.61

u/l

0.41

115

741

Isolated proteinuria

1.37

0.44

1.3

586.86

537.00

u/l

—

Other spirochaetal diseases

847

1.11

0.44

1.3

1.2

304.48

383.41

u/l

0.39

776

Covid-19 suspected case

502

0.86

0.44

1.1

1.2

203.78

300.06

u/l

0.89

461

Respiratory insufficiency

112

1.34

0.44

1.4

1.2

102.25

381.82

u/l

2.38

104

Other diseases of pericardium

1.41

0.43

1.1

1.3

216.00

538.78

u/l

1.20

Certolizumab pegol

1.62

0.43

1.4

1.1

178.80

691.46

u/l

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

366

1.17

0.43

1.1

1.3

174.47

324.81

u/l

2.52

337

Any dementia

647

0.90

0.42

1.2

253.39

351.79

u/l

0.44

589

Seropositive rheumatoid arthritis, wide

612

1.13

0.42

1.4

1.2

273.24

287.11

u/l

0.06

559

Tuberculosis of other organs, strict

1.57

0.42

1.0

140.80

530.85

u/l

—

Dementia

739

0.91

0.41

1.2

250.79

343.42

u/l

0.47

678

Other specified disorders of kidney and ureter

1.38

0.41

1.0

1.2

191.75

461.73

u/l

—

Tuberculosis of other organs, strict, including avohilmo

1.52

0.41

1.0

140.80

517.22

u/l

—

Degenerative diseases of the nervous system

618

0.90

0.41

1.2

172.65

316.60

u/l

2.02

563

Other hammer toe(s) (acquired)

302

1.17

0.41

1.3

1.2

215.38

350.89

u/l

1.24

279

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

133

825

1.09

0.40

1.2

168.43

389.13

u/l

3.23

122

762

Hyperprolactinaemia

1.34

0.40

1.3

1.2

165.00

413.40

u/l

—

Arterial embolism and thrombosis of lower extremity artery

1.33

0.40

1.0

1.1

184.81

436.46

u/l

—

Malignant neoplasm of endocrine gland

141

1.28

0.40

1.0

1.2

165.72

318.33

u/l

1.07

123

Use of rivastigmine

314

1.18

0.40

1.2

189.34

284.26

u/l

0.64

290

Hidradenitis suppurativa

1.31

0.39

1.3

1.2

256.63

471.44

u/l

—

Glaucoma-related operations

101

0.69

0.39

1.0

1.1

230.29

346.53

u/l

—

Failed induction of labour

104

0.67

0.39

1.1

1.3

238.86

249.95

u/l

—

Crystal arthropathies, rheuma endpoint

1.43

0.39

1.2

1.3

144.80

523.57

u/l

—

Polyuria

512

1.13

0.39

1.1

1.2

187.75

433.66

u/l

2.08

468

Burn and corrosion of head and neck

1.43

0.39

1.0

1.2

186.60

542.73

u/l

—

Viral conjunctivitis

1.43

0.39

1.4

1.2

140.20

648.33

u/l

—

Congenital malformations of great arteries

1.40

0.38

1.0

1.2

219.00

571.24

u/l

—

Burn and corrosion of shoulder and upper limb, except wrist and hand

1.39

0.38

1.2

1.1

131.80

631.58

u/l

—

Burns and corrosions of multiple and unspecified body regions

1.39

0.38

1.6

1.2

310.80

512.10

u/l

—

Sequelae of cerebrovascular disease

771

1.10

0.38

1.2

201.93

408.98

u/l

2.47

705

Congenital malformations of heart and great arteries

244

1.19

0.38

1.0

1.3

169.16

367.00

u/l

2.61

226

Non-small cell lung cancer, squamous

1.32

0.37

1.0

1.2

186.56

381.52

u/l

—

Chronic nephritic syndrome

1.31

0.37

1.1

1.2

100.78

440.26

u/l

—

Other disorders of optic [2nd] nerve and visual pathways

107

1.31

0.37

1.1

1.2

223.29

360.55

u/l

0.56

Diabetic retinopathy, excluding more controls

388

1.11

0.36

1.2

122.15

283.65

u/l

1.78

362

Other obstetric trauma

1.34

0.35

1.2

1.3

313.08

244.93

u/l

0.22

Systemic sclerosis (FG)

1.43

0.35

1.0

1.1

131.17

554.64

u/l

—

Male infertility

0.63

0.35

1.2

1.5

560.40

426.38

u/l

—

Hyperplasia of prostate

510

1.09

0.35

1.2

1.3

675.31

362.03

u/l

0.48

475

Unspecified lump in breast

341

0.85

0.34

1.2

1.3

187.76

269.60

u/l

0.60

310

Single spontaneous delivery

526

0.91

0.34

1.2

204.33

241.55

u/l

0.44

489

Actinic keratosis

855

0.91

0.34

1.1

1.2

228.10

334.52

u/l

0.71

786

Benign neoplasm: Liver

1.34

0.33

1.3

1.2

173.00

500.72

u/l

—

Granulomatous disorders of skin and subcutaneous tissue

1.34

0.33

3.5

1.2

149.83

490.18

u/l

—

Entropion and trichiasis of eyelid

136

1.25

0.33

1.3

1.1

122.65

379.02

u/l

2.01

125

Ptosis of eyelid

219

1.19

0.33

1.0

1.2

109.71

337.97

u/l

2.83

200

Malignant neoplasm of stomach

0.67

0.32

2.5

1.2

659.17

377.94

u/l

—

Organic, including symptomatic, mental disorders

141

926

1.07

0.32

1.2

232.92

353.58

u/l

1.01

128

854

Benign neoplasm: other/unspecified salivary gland

1.28

0.32

1.2

154.83

482.52

u/l

—

936

0.92

0.32

1.1

1.2

220.49

331.99

u/l

0.87

862

Diabetic neuropathy

302

1.15

0.32

1.3

1.2

140.19

300.25

u/l

1.14

275

Other/unspecified seropositive rheumatoid arthritis

607

1.10

0.32

1.1

1.2

279.52

287.34

u/l

0.03

554

Unspecified dementia

197

0.82

0.31

1.3

1.2

87.61

296.60

u/l

2.32

184

Renal cell carcinoma of kidney

1.35

0.31

1.0

1.2

210.14

414.09

u/l

—

Exposure to other and unspecified animate mechanical forces

1.35

0.31

1.1

1.2

168.43

489.57

u/l

—

Dementia, including avohilmo

107

786

0.93

0.30

1.2

240.43

337.33

u/l

0.55

723

Dissection of aorta

1.30

0.30

1.1

112.57

365.24

u/l

—

Other noninflammatory disorders of cervix uteri

1.33

0.30

1.3

218.10

173.11

u/l

—

Excessive attrition of teeth

181

1694

1.06

0.30

1.2

1.3

292.70

332.66

u/l

0.27

161

1583

Skin changes due to chronic exposure to nonionizing radiation

882

0.92

0.30

1.1

1.2

223.52

332.94

u/l

0.78

812

Undefined dementia

201

0.83

0.30

1.3

1.1

87.61

277.78

u/l

2.38

187

Allergic conjunctivitis

162

1470

1.06

0.29

1.7

1.2

219.84

299.41

u/l

1.39

154

1367

Systemic lupus erythematosus, unspecified

1.25

0.29

1.0

1.2

406.14

456.96

u/l

—

Benign neoplasm: Conjunctiva

1.25

0.29

1.0

1.3

151.00

470.18

u/l

—

Atopic dermatitis, strict definition

691

1.09

0.29

1.2

1.3

178.55

317.14

u/l

2.68

636

Malignant neoplasm of stomach, including Hilmo

106

0.75

0.29

2.1

1.2

534.25

356.27

u/l

—

Basal cell carcinoma, including Hilmo

126

798

1.07

0.28

1.2

176.30

332.09

u/l

2.59

115

736

Abrasion of teeth

951

0.92

0.28

1.1

1.3

425.36

329.47

u/l

0.28

876

Malignant neoplasm of other connective and soft tissue, including Hilmo

1.32

0.28

1.5

1.2

845.30

435.91

u/l

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

603

1.10

0.28

1.2

283.33

288.71

u/l

0.02

550

Disorder of external ear, unspecified

1.27

0.27

1.4

1.3

165.50

472.03

u/l

—

Bicuspidal aortic valve syndrome

1.27

0.27

1.0

1.4

144.13

442.89

u/l

—

Burn and corrosion of wrist and hand

1.27

0.27

1.1

1.3

284.75

455.30

u/l

—

Infectious mononucleosis

159

1.20

0.26

1.2

1.3

132.63

354.17

u/l

2.02

144

Infectious mononucleosis, including avohilmo

159

1.20

0.26

1.2

1.3

132.63

354.17

u/l

2.02

144

Persons encountering health services in circumstances related to reproduction

149

1056

0.95

0.26

1.2

1.3

272.83

335.99

u/l

0.55

136

984

Systemic atrophies primarily affecting the central nervous system

0.70

0.26

1.4

1.2

122.74

415.73

u/l

—

Postpartum haemorrhage

436

1.10

0.26

1.2

1.3

177.49

233.93

u/l

1.03

411

Pustulosis palmaris et plantaris

1.22

0.25

1.9

1.3

198.56

391.94

u/l

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

151

1232

0.95

0.23

1.2

1.3

371.76

313.81

u/l

0.13

143

1150

Delivery, wide proxy

422

0.93

0.22

1.1

1.2

333.47

225.51

u/l

0.33

391

Other specified and unspecified disorders of choroid

0.00

0.21

0.0

1.2

—

1092.10

—

Adult-onset Still disease

0.00

0.21

0.0

1.2

—

1122.55

—

Viral agents as the cause of diseases classified to other chapters, including avohilmo

1.19

0.21

1.2

1.3

485.60

507.92

u/l

—

Other disorders of veins

100

1042

0.94

0.21

1.2

248.46

322.88

u/l

0.47

966

Papilloedema, unspecified

1.16

0.21

1.0

1.3

401.80

535.05

u/l

—

Other menopausal disorders

309

1.08

0.20

1.2

404.44

228.11

u/l

0.49

289

Systemic sclerosis

1.25

0.20

1.0

1.2

131.17

484.31

u/l

—

Amputation of foot

1.25

0.20

1.0

1.2

137.17

434.19

u/l

—

Other congenital malformations of circulatory system

1.25

0.20

1.2

1.3

529.50

502.19

u/l

—

Laparoscopic right hemicolectomy

108

1.20

0.20

1.2

639.15

291.19

u/l

0.31

100

Sequelae of injuries of neck and trunk

1.23

0.20

1.3

97.00

529.84

u/l

—

Glaucoma

157

1276

1.04

0.20

1.1

1.2

227.43

338.60

u/l

1.09

139

1191

Other disorders of cornea

193

1.14

0.19

1.4

1.2

118.91

378.05

u/l

2.87

175

Benign neoplasm: Liver/bile ducts

1.18

0.19

1.3

1.2

173.00

480.57

u/l

—

Iron deficiency

1.18

0.19

1.0

1.2

317.33

444.11

u/l

—

Erosion of teeth , including avohilmo

665

1.07

0.19

1.5

1.3

282.98

331.79

u/l

0.30

608

Malignant neoplasm of skin, including Hilmo

147

941

1.05

0.19

1.2

205.01

368.83

u/l

2.05

134

871

Combinations of oral blood glucose lowering drugs

675

1.07

0.19

1.2

1.3

207.35

445.49

u/l

2.67

624

Hypogonadotropic hypogonadism

1.15

0.19

1.2

1.3

394.00

651.93

u/l

—

Vascular syndromes of brain in cerebrovascular disorders

1.24

0.18

1.1

1.2

141.20

358.19

u/l

—

1.22

0.18

1.3

1.1

114.36

353.85

u/l

1.32

SLE, ICD10

1.21

0.18

1.0

1.2

406.14

440.77

u/l

—

SLE, strict definition

1.21

0.18

1.0

1.2

406.14

440.77

u/l

—

Basal cell carcinoma

120

780

1.05

0.18

1.2

177.17

337.05

u/l

2.58

109

718

Systemic lupus erythematosus

1.17

0.17

1.0

1.2

406.14

428.25

u/l

—

Malignant neoplasm of skin

138

894

1.04

0.17

1.2

211.11

374.91

u/l

1.89

127

826

Hereditary corneal dystrophies

1.13

0.17

1.3

1.2

118.71

432.68

u/l

—

Giant cell arteritis

0.73

0.17

1.8

1.2

79.00

384.85

u/l

—

Complications of the puerperium, not elsewhere classified

0.73

0.17

1.0

1.2

320.40

247.20

u/l

—

Other other unspecified disorders of the circulatory system

0.71

0.16

1.2

217.60

428.65

u/l

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

1.16

0.16

1.3

1.2

174.50

391.57

u/l

—

Multiple delivery

162

0.86

0.16

1.0

1.2

222.21

275.72

u/l

0.23

145

Benign neoplasm of eye and adnexa

206

1.12

0.16

1.4

1.2

222.63

317.62

u/l

0.56

190

Congenital malformations of aortic and mitral valves

1.15

0.15

1.0

1.4

135.89

450.36

u/l

—

Chronic suppurative otitis media, including avohilmo

140

1.14

0.15

4.2

1.3

171.06

323.39

u/l

0.95

127

Cardiodefibrillation

896

1.05

0.14

1.2

239.20

386.98

u/l

1.57

829

Melanoma in situ

0.81

0.14

1.0

1.2

214.29

370.21

u/l

—

Family history of certain disabilities and chronic diseases leading to disablement

1.18

0.14

1.0

1.2

138.91

378.38

u/l

1.32

Malignant melanoma

337

0.92

0.14

1.1

1.2

352.45

422.19

u/l

0.18

305

Malignant neoplasm of thyroid gland

131

1.15

0.14

1.0

1.2

176.27

326.77

u/l

0.92

114

Pustular psoriasis

1.19

0.14

1.8

1.3

183.10

374.52

u/l

—

Other benign neoplasms of uterus

1.19

0.14

2.0

1.2

253.40

328.17

u/l

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

148

1372

1.03

0.13

1.7

1.2

225.95

306.67

u/l

1.26

140

1274

Polypectomy (DHB20)

123

1.14

0.12

1.1

1.3

165.29

419.30

u/l

1.75

116

Impacted maxillary molar

116

0.86

0.12

1.1

1.2

362.50

367.09

u/l

—

104

Coxarthrosis, primary, with hip surgery

125

1122

1.03

0.11

1.2

244.69

344.30

u/l

0.80

118

1038

Benign neoplasm: salivary glands, exclude unknown (D119)

168

0.89

0.11

1.4

1.3

173.33

321.28

u/l

0.95

157

Ulcer of lower limb, not elsewhere classified

308

1.07

0.11

1.2

234.81

308.71

u/l

0.37

284

Other disorders of penis

192

1.09

0.10

1.0

1.3

139.67

522.66

u/l

2.58

176

Other and specified injuries of hip and thigh

1.14

0.10

1.8

1.3

1982.20

256.03

u/l

—

Malignant neoplasm of cervix uteri, including Hilmo

1.09

0.09

1.4

1.1

164.00

535.39

u/l

—

Malignant neoplasm of rectosigmoid junction, including Hilmo

1.09

0.09

1.2

1.3

170.20

452.98

u/l

—

Myelodysplastic syndrome, including Hilmo

1.06

0.09

1.2

258.00

456.23

u/l

—

Scissor bite

1.05

0.09

1.4

1.2

189.60

461.46

u/l

—

All dysplastic lesions of the cervix uteri, vagina or vulva

638

1.04

0.09

1.3

168.13

243.98

u/l

1.67

597

Generalized epilepsy, mode (most common among epilepsy diagnosis)

1.11

0.09

1.0

1.3

171.00

465.02

u/l

—

Sixth [abducent] nerve palsy

1.07

0.08

1.8

1.3

251.17

483.22

u/l

—

Other sexually transmitted chlamydial diseases

113

0.88

0.08

1.2

1.3

362.30

396.99

u/l

—

103

Vertical strabismus

0.82

0.08

1.0

1.2

90.80

452.64

u/l

—

Postpartum hemorraghe, all women as controls

544

1.04

0.08

1.2

1.3

177.49

247.66

u/l

1.29

512

SLE (Finngen)

1.09

0.08

1.0

1.2

406.14

440.42

u/l

—

Other inflammation of vagina/vulva

1.09

0.08

1.0

1.2

218.29

258.41

u/l

—

Other congenital malformations of skin

1.03

0.07

1.1

1.4

156.57

388.95

u/l

—

Disorders of speech understanding and production

1.02

0.07

1.3

1.2

354.57

477.66

u/l

—

Other surgical follow-up care

0.86

0.07

1.0

1.2

138.23

412.19

u/l

—

Benign neoplasm: Skin of ear and external auricular canal

0.86

0.07

1.2

1234.00

419.67

u/l

—

Helminthiases, including avohilmo

0.84

0.07

1.2

1.3

215.00

415.08

u/l

—

Benign neoplasm of other and unspecified female genital organs

0.81

0.07

1.0

1.2

166.33

378.13

u/l

—

Fracture of forearm

148

1354

0.98

0.06

1.2

213.65

349.62

u/l

1.60

141

1247

Care involving use of rehabilitation procedures

180

1644

0.98

0.06

1.1

1.3

230.36

285.19

u/l

1.05

162

1540

Seborrhoeic keratosis

601

1.03

0.06

1.2

152.66

401.77

u/l

2.87

555

Benign neoplasm of major salivary glands

187

1.07

0.06

1.3

1.2

173.25

342.44

u/l

1.33

174

Malignant neoplasm of thyroid gland, including Hilmo

139

1.08

0.05

1.0

1.2

176.27

319.11

u/l

0.91

121

Caught, crushed, jammed or pinched in or between objects

100

1.10

0.05

1.8

1.4

702.18

452.60

u/l

0.19

Melanocytic naevi

766

0.98

0.04

1.1

1.3

222.70

306.38

u/l

1.05

708

Exposure to unspecified factor

307

2068

1.01

0.04

1.3

1.2

478.76

291.38

u/l

0.88

280

1938

Benign neoplasm: Parotid gland

150

0.93

0.04

1.4

1.3

181.14

335.60

u/l

0.90

142

Postpartum hemorraghe, parous women as controls

473

1.03

0.04

1.2

1.3

177.49

256.17

u/l

1.41

446

Any dementia, excluding more controls

532

1.02

0.03

1.2

1.1

262.70

379.81

u/l

0.48

487

Other complications of labour and delivery, not elsewhere classified

204

0.96

0.03

1.1

1.3

212.00

232.73

u/l

0.14

189

Chalazion

230

1.04

0.03

1.0

1.3

1120.25

371.94

u/l

0.36

211

Primary open-angle glaucoma

714

0.98

0.03

1.1

1.2

256.87

305.70

u/l

0.18

656

L02BX Other hormone antagonists and related agents

102

1.08

0.03

1.1

264.45

319.29

u/l

0.23

Pregnancy, childbirth and the puerperium

351

0.98

0.03

1.2

311.16

222.99

u/l

0.23

326

Primary open-angle glaucoma, strict

597

0.99

0.01

1.1

1.2

289.06

314.14

u/l

0.07

549

Spontaneous abortion

107

722

0.99

0.01

1.3

1.2

206.20

263.27

u/l

0.56

100

681

L01XX Other antineoplastic agents

104

1.06

0.01

1.8

1.2

270.82

368.22

u/l

0.26

Malignant melanoma of skin

234

1.03

0.00

1.1

1.2

399.62

339.25

u/l

0.15

208

Chronic suppurative otitis media

118

1.02

0.00

5.2

1.3

184.17

343.15

u/l

0.76

107

Benign neoplasm: Choroid

124

0.97

0.00

1.7

1.3

282.12

317.06

u/l

0.10

112

Other mental disorders due to brain damage and dysfunction and to physical disease

254

0.98

0.00

1.1

1.2

173.90

330.41

u/l

1.55

235

Papillary adenocarcinoma of thyroid gland

102

0.98

0.00

1.0

1.2

189.20

370.74

u/l

—

Benign leiomyoma with endometriosis

348

1.01

0.00

1.3

1.2

409.30

241.68

u/l

0.29

317

Hypermetropia

148

1.01

0.00

1.6

1.3

195.60

312.51

u/l

0.63

136

Congenital malformations of eye, ear, face and neck

114

0.96

0.00

1.5

1.3

157.09

386.46

u/l

1.23

100

Malignant neoplasm of bladder

104

0.96

0.00

1.2

203.90

335.22

u/l

—

Thyrotoxicosis with toxic multinodular goitre

103

0.97

0.00

1.0

1.2

159.80

330.81

u/l

—

Nondiabetic hypoglycaemic coma

0.00

0.0

1.4

—

132.20

—

Benign neoplasm: Scrotum

0.00

0.0

1.2

—

127.56

—

0.00

0.0

1.4

—

2301.40

—

Other specified/unspecified diseases of inner ear

0.00

0.0

1.3

—

118.50

—

Acute disseminated encephalitis/encephalomyelitis

0.00

0.0

1.4

—

137.00

—

Other sex chromosome abnormalities, male phenotype, not elsewhere classified

0.00

0.0

1.4

—

451.40

—

Carcinoma in situ of skin of lip

0.00

0.0

1.0

—

254.60

—

Pityriasis lichenoides et varioliformis acuta

0.00

0.0

1.0

—

1699.00

—

Feeding problems of newborn

0.00

0.0

1.8

—

134.33

—

Fitting and adjustment of external prosthetic device

0.00

0.0

1.3

—

1467.00

—

Degenerative conditions of globe

0.00

-0.00

0.0

1.0

—

102.40

—

Calculus of lower urinary tract

0.92

-0.00

1.4

1.2

155.63

457.61

u/l

—

Metabolic disorder, other/unspecified

0.00

-0.00

0.0

1.3

—

405.56

—

Defect, injury or illness of face

0.00

-0.00

0.0

1.0

—

421.40

—

Other specified/unspecified disorders of middle ear and mastoid

0.00

-0.00

0.0

1.0

—

115.40

—

Failure of sterile precautions during surgical operation

0.00

-0.00

0.0

1.0

—

130.43

—

Listeriosis, including avohilmo

0.00

-0.00

0.0

1.0

—

120.00

—

Gonococcal infection, including avohilmo

1.00

-0.00

1.3

155.83

572.40

u/l

—

Accident to watercraft causing drowning and submersion

0.00

-0.00

0.0

1.0

—

449.00

—

Other acantholytic disorders

0.00

-0.00

0.0

1.0

—

120.83

—

Polyglandular dysfunction

0.00

-0.00

0.0

1.0

—

141.20

—

Discharge from other and unspecified firearms

0.00

-0.00

0.0

1.5

—

171.00

—

Transient acantholytic dermatosis [Grover]

0.00

-0.00

0.0

1.0

—

125.40

—

Subacute thyroiditis

0.87

-0.00

1.3

1.2

86.00

409.22

u/l

—

Other fibroblastic disorders

0.00

-0.00

0.0

1.3

—

183.14

—

Fatigue fracture of vertebra

0.00

-0.00

0.0

1.0

—

236.33

—

Intermittent hydrarthrosis

0.00

-0.00

0.0

1.0

—

2548.40

—

Listeriosis

0.00

-0.00

0.0

1.0

—

120.00

—

Crushing injury of forearm

0.00

-0.00

0.0

1.3

—

101.33

—

Maternal care for cervical incompetence

0.92

-0.00

1.0

1.1

244.50

412.85

u/l

—

Gonococcal infection

0.88

-0.00

1.4

1.2

173.40

458.40

u/l

—

L01XE Protein kinase inhibitors

0.92

-0.00

1.6

1.2

959.22

403.79

u/l

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

-0.00

0.0

2.0

—

136.40

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.4

—

138.20

—

Marasmic kwashiorkor

0.00

-0.00

0.0

1.4

—

187.60

—

Pterygium

0.94

-0.00

1.0

1.3

173.40

416.42

u/l

—

Congenital retinoschisis

0.00

-0.00

0.0

1.4

—

410.80

—

Traumatic cerebral oedema

0.00

-0.00

0.0

1.0

—

497.67

—

Postprocedural disorders of eye and adnexa, not elsewhere classified

0.00

-0.00

0.0

1.0

—

151.20

—

Organ-limited amyloidosis

0.00

-0.00

0.0

1.0

—

189.43

—

Abuse of non-dependence-producing substances

0.00

-0.00

0.0

1.4

—

419.40

—

Carcinoma in situ of prostate

0.00

-0.00

0.0

1.0

—

223.14

—

Benign neoplasm: Testis

0.00

-0.00

0.0

1.3

—

362.12

—

Felty syndrome

0.00

-0.00

0.0

1.3

—

110.13

—

Cerebral oedema

0.00

-0.00

0.0

1.3

—

120.67

—

Malignant neoplasm of peripheral nerves and autonomic nervous system, including Hilmo

0.00

-0.00

0.0

1.0

—

391.00

—

Mononeuritis multiplex

0.00

-0.00

0.0

1.0

—

1694.50

—

Disorders of hypoglossal nerve

0.00

-0.00

0.0

1.0

—

2023.00

—

Disorders of olfactory nerve

0.00

-0.00

0.0

1.0

—

2304.00

—

Other secondary gout

0.00

-0.00

0.0

1.0

—

137.86

—

Urethral discharge

0.00

-0.00

0.0

1.4

—

442.80

—

Congenital retinoschisis

0.00

-0.00

0.0

1.4

—

410.80

—

Other abnormal findings of blood chemistry

0.94

-0.00

1.4

1.2

152.00

392.56

u/l

—

Malignant neoplasm of gum

0.00

-0.00

0.0

1.4

—

181.20

—

Toxic erythema

0.00

-0.00

0.0

1.4

—

1976.60

—

Explosion of other materials

0.00

-0.00

0.0

1.3

—

392.50

—

Hypersensitivity angiitis

0.00

-0.00

0.0

1.0

—

108.00

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Amylase [Enzymatic activity/volume] in Urine

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS